WWW.DISSERS.RU


...
    !

Pages:     | 1 |   ...   | 2 | 3 ||

613.83 51.1(2)5 61 Lynn Zimmer and John P. Morgan, 1997 Drug Policy Alliance All rights reserved. ...

-- [ 4 ] --

31. Block R.I. et al. Long Term Marijuana Use and Subsequent Effects on Learning and Cognitive Functions Related to School Achievement: Preliminary Study, pp. 96111 in Spencer J.W., Boren J.J. (eds) Residual Effects of Abused Drugs on Behavior, Rockville, MD: National Institute on Drug Abuse (1990).

32. Pope H.G., Yurgelun Todd D. The Residual Cognitive Effects of Heavy Marijuana Use, Journal of the American Medical Association 275: 52127 (1996).

33. Schwartz R.H. et al. Short Term Memory Impairment in Cannabis Dependent Adolescents, American Journal of Diseases of Children 143: 121418 (1989), p. 1215.

34. Schwartz R.H. et al. (1989), . 33, p. 1214.

35. Nahas G., Latour C. The Human Toxicity of Marijuana, The Medical Journal of Australia 156: 495 (1992);

Hall W. et al. The Health and Psychological Consequences of Cannabis Use, Canberra: Australian Government Publishing Service (1994);

Adams I.B., Martin B.R. Cannabis: Pharmacology and Toxicity in Animals and Humans, Addiction 91: 15851614 (1996).

36. Schwartz R.H. et al. (1989), . 33, p. 1218.

37. In the part of the paper describing the data analysis (p. 1217), the community sample (Group B) is mislabeled Group C. Figure 2 (p. 1218) presents a graphic illustration of scores on the Wechsler Test, with the community sample and the program sample labeled properly. Schwartz R.H. et al. (1988), . 33.

38. Deadwyler S.A. et al. The Effects of Delta 9 THC on Mechanisms of Learning and Memory, pp. 79 in Erinoff L. (ed) Neurobiology of Drug Abuse: Learning and Memory, Rockville, MD: National Institute on Drug Abuse (1990);

Lichtman A.H. et al. Systemic or Intrahippocampal Cannabinoid Administration Impairs Spatial Memory in Rats, Psychopharmacology 119: 28290 (1995).

10. , 1. Lapey J.D. Marijuana Update 1996, Drug Watch International, Omaha (1996).

2. German T.J. Marijuana is NOT a Medicine, Santa Clarita, CA: California Narcotic Officers' Association (1996), p. 33.

3. Center for Substance Abuse Prevention, Reality Check: Questions and Answers, Rockville, MD: U.S.

Department of Health and Human Services (1996).

4. Nahas G.G., Latour C. The Human Toxicity of Marijuana, Medical Journal of Australia 156 (1994), p. 497.

5. Fossier A.E. The Marihuana Menace, New Orleans Medical and Surgical Journal 84: 24752 (1931);

Merrill F.T. Marihuana: The New Dangerous Drug. Washington, DC: Foreign Policy Association (1938);

Rowell E.A., Rowell R. On the Trail of Marihuana, the Weed of Madness, Mountain View, CA: Pacific Press Publishing Association (1939).

6. Chopra G.S. Man and Marihuana, International Journal of the Addictions 4: 1547 (1969);

Brill H., Nahas G.G. Cannabis Intoxication and Mental Illness, pp. 263305 in Nahas G.G. (ed) Marihuana in Science and Medicine, New York: Raven Press (1984).

7. Grinspoon L. Marihuana Reconsidered, Cambridge, MA: Harvard University Press (1971);

Kaplan J.

Marijuana: The New Prohibition, New York: World Publishing Company (1970);

National Commission on Marihuana and Drug Abuse, Marihuana: A Signal of Misunderstanding, Washington, DC: U.S. Government Printing Office (1972).

8. Allebeck P. et al. Cannabis and Schizophrenia: A Longitudinal Study of Cases Treated in Stockholm County, Acta Psychiatrica Scandinavica 88: 2124 (1993).

9. Hall W. et al. Tbe Health and Psychological Consequences of Cannabis Use, Canberra: Australian Government Publishing Service (1994);

Thornicroft G. Cannabis and Psychosis: Is There Epidemiological Evidence for Association?, British Journal of Psychiatry 157: 2533 (1990);

Hollister L.E. Health Aspects of Cannabis, Pharmacological Reviews 38: 120 (1986).

10. Negrete J.C. et al. Cannabis Affects the Severity of Psychiatric Symptoms: Results of a Clinical Survey, Psychological Medicine 16: 51520 (1986).

134 : 11. Mueser K.T. et al. Prevalence of Substance Abuse in Schizophrenia: Demographic and Clinical Correlates, Schizophrenia Bulletin 16: 3156 (1990);

Warner R. et al. Substance Use Among the Mentally Ill: Prevalence, Reasons for Use, and Effects on Illness, American Journal of Orthopsychiatry 64: 3039 (1994).

12. Andreasson S. et al. Cannabis and Schizophrenia: A Longitudinal Study of Swedish Conscripts, Lancet 2: 148386 (1987).

13. Andreasson S. et al. Schizophrenia in Users and Nonusers of Cannabis: A Longitudinal Study in Stockholm County, Acta Psychiatrica Scandinavica 79: 50510(1989).

14. Johnson B.A. et al. Cannabis and Schizophrenia, Lancet 1: 59293 (1988);

Negrete J.C. Cannabis and Schizophrenia, British Journal of Addiction 84: 34951 (1989).

15. Der G. et al. Is Schizophrenia Disappearing, Lancet 1: 51316 (1990).

16. McGlothlin W.H., West L.J. The Marihuana Problem: An Overview, American Journal of Psychiatry 125:

37078 (1968);

Kolansky H., Moore W.T. Clinical Effects of Marihuana on the Young, International Journal of Psychiatry 10: 5567 (1972);

Rodgers T.C. Discussion, American Journal of Psychiatry 130:13940 (1973).

17. Jessor R. et al. Psychosocial Correlates of Marijuana Use and Problem Drinking in a National Sample of Adolescents, American Journal of Public Health 70: 60413 (1980);

Pandina R.J. et al. The Impact of Prolonged Marijuana Use on Personal and Social Competence in Adolescence, pp. 183200 in Chesher G. et al. (eds) Marijuana:

An International Research Report, Canberra: Australian Government Publishing Service (1988);

Shedler J., BlockJ.

Adolescent Drug Use and Psychological Health: A Longitudinal Inquiry, American Psychologist 45: 612 (1990);

Dembo R. et al. A Longitudinal Study of the Relationship Among Alcohol Use, Marijuana / Hashish Use, Cocaine Use, and Emotional / Psychological Functioning Problems in a Cohort of High Risk Youths, International Journal of the Addictions 25: 134182 (1990).

18. MacDonald D.I. The Relationship of Moderate Marijuana Use and Adolescent Behavior, pp. 4551 in Marijuana and Youth: Clinical Observations on Motivation and Learning, Rockville, MD: National Institute on Drug Abuse (1982);

Voth H.M. The Effects of Marijuana on the Young, pp. 5155 in Marijuana and Youth: Clinical Observations on Motivation and Learning, Rockville, MD: National Institute on Drug Abuse (1982);

Gold M.S.

Marijuana, New York: Plenum Medical Book Company (1989);

DuPont R.L. Getting Tough on Gateway Drugs:

A Guide for the Family, Washington, DC: American Psychiatric Press (1984);

Millman R.B., Sbriglio R. Patterns of Use and Psychopathology in Chronic Marijuana Users, Pediatric Clinics of North America 9: 53345 (1986).

19. Farrell A.D. et al. Relationship Between Drug Use and Other Problem Behaviors in Urban Adolescents, Journal of Consulting and Clinical Psychology 60: 70512 (1992);

Donovan J.E., Jessor R. Structure of Problem Behavior in Adolescence and Young Adulthood, Journal of Consulting and Clinical Psychology 53: 890 (1985);

Hendin H. et al. Adolescent Marijuana Abusers andTheir Families, Rockville, MD: National Institute on Drug Abuse (1981);

Kellam S. et al. The Prevention of Teenage Substance Use: Longitudinal Research and Strategy, pp.

171200 in Petersen A. Perry C. (eds) Promoting Adolescent Health: A Dialogue on Research and Practice, New York: Academic Press (1982);

Block J. et al. Longitudinally Foretelling Drug Usage in Adolescence: Early Childhood Personality and Environmental Precursors, Child Development 59: 33655 (1988);

Johnston L.D. et al. Drugs and Delinquency: A Search for Causal Connections, pp. 13756 in Kandel D.B. (ed) Longitudinal Research on Drug Use: Empirical Findings and Methodological Issues, New York: John Wiley & Sons (1978);

Tubman J.G. et al.

Qualitative Changes in Relationships Between Substance Use and Adjustment During Adolescence, Journal of Substance Abuse 3: 40514 (1991);

ShedlerJ., Block J.(1990), . 15;

Pandina R.J. et al. (1988), . 15;

Dembo R. et al. (1990), . 17.

20. Hendin H. et al. Adolescent Marijuana Abusers and Their Families, Rockville, MD: National Institute on Drug Abuse (1981).

21. Jessor R. Marihuana: A Review of Recent Psychosocial Research, pp. 33755 in DuPont R.L. et al. (eds) Handbook on Drug Abuse, Rockville, MD: National Institute on Drug Abuse (1979);

Eisenman R. et al.

Undergraduate Marijuana Use as Related to Internal Sensation, Novelty Seeking and Openness to Experience, Journal of Clinical Psychology 36: 101319 (1980);

Satinder K.P., Black A. Cannabis Use and Sensation Seeking Behavior, Journal of Psychology 116: 10105 (1984);

Kandel D.B. Marijuana Users in Young Adulthood, Archives of General Psychiatry 41: 20009 (1984);

Mayer J.E., Ligman J.D. Personality Characteristics of Adolescent Marijuana Users, Adolescence 24: 96576 (1989);

Fisher G., Steckler A. Psychological Effects, Personality and Behavioral Changes Attributed to Marihuana, International Journal of the Addictions 9: 101 (1974);

Brook J.S. Family Socialization and Adolescent Personality and Their Association with Adolescent Use of Marijuana, Journal of Genetic Psychology 133: 26171 (1978).

22. Kay E.J. et al. A Longitudinal Study of the Personality Correlates of Marijuana Use, Journal of Consulting and Clinical Psychology 46: 47077(1978);

Pederson W. Mental Health, Sensation Seeking and Drug Use Patterns:

A Longitudinal Study, British Journal of Addiction 86: 195204 (1991);

Smith G.M., Fogg C.P. Psychological Predictors of Early Use, Late Use, and Nonuse of Marijuana Among Teenage Students, pp. 10113 in Kandel D.P.

(ed) Longitudinal Research on Drug Use: Empirical Findings and Methodological Issues, New York: John Wiley & Sons (1978).

23. Hogan R. et al. Personality Correlates of Undergraduate Marijuana Use, Journal of Consulting and Clinical Psychology 35: 5863 (1970);

McAree C.P. et al. Personality Factors and Patterns of Drug Usage in College Students, American Journal of Psychiatry 129: 89093 (1972);

Richek H.G. et al. Personality / Mental Health Correlates of Drug Use by High School Students, Journal of Nervous and Mental Disease 160: 43542 (1975);

Goldstein J.W., Sappington J.T. Personality Characteristics of Students Who Became Heavy Drug Users: An MMPI Study of an Avant Guard, American Journal of Drug and Alcohol Abuse 4: 40112 (1977);

Hochman J.S., Brill N.Q. Chronic Marihuana Use and Psychosocial Adaptation, American Journal of Psychiatry 130: 132 (1973).

24. Shedler J. Block J. (1990), . 17.

25. Weil A. Adverse Reactions to Marijuana: Classification and Suggested Treatment, New England Journal of Medicine 282: 9971000 (1970);

Smith D.E. Acute and Chronic Toxicity of Marijuana, Journal of Psychedelic Drugs 2: 3747 (1968);

Meyer M.E. Psychiatric Consequences of Marihuana Use: The State of the Evidence, pp.

13352 in Tinklenberg J.R. (ed) Marihuana and Health Hazards: Methodologic Issues in Current Research, New York: Academic Press (1975);

Abruzzi W. Drug Induced Psychosis, International Journal of the Addictions 12:

18393 (1977).

26. Mason A.P., McBay A.J. Cannabis: Pharmacology and Interpretation of Effects, Journal of Forensic Sciences 30: 61531 (1985);

Wall M.E., Perez Reyes M. The Metabolism of Delta 9 Tetrahydrocannabinol and Related Cannab inoids in Man, Joumal of Clinical Pharmacology 21: 17889S (1981).

27. Perez Reyes M. et al. Intravenous Injection in Man of Delta 9 Tetrahydrocannabinol and 11 Hydroxy Delta 9 Tetrahydrocannabinol, Science 177: 63335 (1972);

Perez Reyes M. et al. A Comparison of the Pharmacological Activity of Delta 9 Tetrahydrocannabinol and Its Monohydroxylated Metabolites in Man, Experientia 29: 100910 (1973);

Lemberger L. et al. Comparative Pharmacology of Delta 9 Tetrahydrocannabinol and its Metabolite 11 OH Delta 9 THC, Journal of Clinical Investigation 54: 241117 (1973);

Agurell S. et al.

Pharmacokinetics and Metabolism of Delta 9 Tetrahydrocannabinol and Other Cannabinoids with Emphasis on Man, Pharmacological Reviews38: 2143 (1986).

28. Jones R. et al. Clinical Studies of Cannabis Tolerance and Dependence, Annals of the New York Academy of Sciences 282: 22139 (1976).

29. Ritzlin R.S. et al. Delta 9 Tetrahydrocannabinol Levels in Street Samples of Marijuana and Hashish:

Correlation to User Reactions, Clinical Toxicology 15: 4553 (1979).

30. Ungerleider J.T., Andrysiak T. Bias and the Cannabis Researcher, Journal of Clinical Pharmacology 21:

15358S (1981).

31. Mathers DC., Ghodse A.H. Cannabis and Psychotic Illness, British Journal of Psychiatry 161: 64853 (1992);

Thomas H. Psychiatric Symptoms in Cannabis Users, British Journal of Psychiatry 163: 14149 (1993).

32. Grossman W. Adverse Reactions Associated with Cannabis Products in India, Annals of Internal Medicine 70: 52933 (1969);

Chopra G.S., Smith J.W. Psychotic Reactions Following Cannabis Use in East Indians, Archives of General Psychiatry 30: 2427 (1974);

Chaudry H.R. et al. Cannabis Psychosis Following Bhang Ingestion, British Journal of Addiction 86: 107581 (1991).

33. Hollister L.E. (1986), . 9.

34. Keeler M.H. et al. Spontaneous Recurrence of Marihuana Effect, American Journal of Psychiatry 125:384 86 (1968);

Annis H.M., Smart R.G. Adverse Reactions and Recurrences from Marijuana Use, British Journal of Addiction 68: 31519 (1973);

Edwards G. Cannabis and the Psychiatric Position, pp. 32040 in Graham, J.D.P. Cannabis and Health, New York: Academic Press (1976);

Stanton M.D. et al. Drug Flashbacks. II. Some Additional Findings, International Journal of the Addictions 11: 5369 (1976);

Brown A., Stickgold A. Marijuana Flashback Phenomena, Journal of Psychedelic Drugs 8: 27583 (1976).

35. Weil A. The Natural Mind, Boston: Houghton Mifflin Company (1972).

11. , 1. Shalala D. Secretary of Health and Human Services, Say 'No' to Legalization of Marijuana, Wall Street Journal (18 August 1995), p. A10.

136 : 2. Brown L. Director of National Drug Control Policy, remarks at National Conference on Marijuana Use:

Prevention, Treatment, and Research, sponsored by the National Institute on Drug Abuse, Arlington, VA (July 1995).

3. Schwartz R.H. Marijuana: A Crude Drug with a Spectrum of Unappreciated Toxicity, Pediatrics 73 (1984), p. 457.

4. Bonnie R.J., Whitebread C.H. The Marihuana Conviction: A History of Marihuana Prohibition in the United States, Charlottesville: University of Virginia Press (1974);

Kaplan J. Marijuana: The New Prohibition, New York:

The World Publishing Company (1970).

5. Anslinger H.J., Cooper C. Assassin of Youth, American Magazine 124 (July 1937).

6. National Commission on Marihuana and Drug Abuse, Marihuana: A Signal of Misunderstanding, Washington, DC: U.S. Government Printing Office (1972), p. 77.

7. Drug Use Forecasting: 1993 Annual Report on Juvenile Arrestees / Detainees, Washington, DC: U.S.

Department of Justice (1994);

Harrison L., Gfroerer J. The Intersection of Drug Use and Criminal Behavior, Crime and Delinquency 38: 42243 (1992);

Leukefeld C.G., Clayton R. Drug Abuse and Delinquency: A Study of Youths in Treatment, pp. 21328 in Bescher G. Friedman A. (eds) Youth Drug Abuse: Problems, Issues and Treatment, Lexington, MA: DC Heath (1979);

O'Donnell J.A. et al. Young Men and Drugs: A Nationwide Survey, Rockville, MD: National Institute on Drug Abuse (1976);

Dembo R. et al. Examination of the Relationships Among Drug Use, Emotional / Psychological Problems, and Crime Among Youths Entering a Juvenile Detention Center, International Journal of Addictions 25: 30140 (1990);

Anthony J.C. Young Adult Marijuana Use in Relation to Antecedent Misbehavior, pp. 23844 in Harris L.S. (ed) Problems of Drug Dependence, 1984, Rockville, MD:

National Institute on Drug Abuse (1985);

Jessor R., Jessor S.L. Problem Behavior and Psychosocial Development:

A Longitudinal Study of Youth, New York: Academic Press (1977);

Farrell A.D. et al. Relationship Between Drug Use and Other Problem Behaviors in Urban Adolescents, Joumal of Consulting and Clinical Psycology 60: 705 (1992).

8. Fagan J. et al. Delinquency and Substance Use Among Inner City Students, Journal of Drug Issues 20:

351402 (1990);

Ausubel D.B. Drug Addiction: Physiological, Psychological and Sociological Aspects, New York:

Random House (1958);

Johnson (1973), . 7.

9. Simonds J.E., Kashani J. Specific Drug Use and Violence in Delinquent Boys, American Journal of Drug and Alcohol Abuse 7: 30522 (1980);

Johnston L.D. et al. Drugs and Delinquency: A Search for Causal Connections, pp. 13756 in Kandel D.B. (ed) Longitudinal Research on Drug Use: Empirical Findings and Methodological Issues, New York: John Wiley & Sons (1978);

Goode E. Marijuana and Crime, pp. 44753 in National Commission on Marihuana and Drug Abuse, Marihuana: A Signal of Misunderstanding, Appendix I, Washington, DC: U.S. Government Printing Office (1972).

10. Clayton R.R. The Delinquency and Drug Use Relationship Among Adolescents, pp. 82103 in Lettieri D.J. Ludford J.P. (eds) Drug Abuse and the American Adolescent, Rockville, MD: National Institute on Drug Abuse (1981);

Jessor R. Marihuana: A Review of Recent Psychosocial Research, pp. 33756 in DuPont R.L. et al.(eds) Handbook on Drug Abuse, Rockville, MD: National Institute on Drug Abuse (1979).

11. Tinklenberg J.R. et al. Drugs and Criminal Assaults by Adolescents: A Replication Study, Journal of Psychoactive Drugs 13: 27787 (1981);

Goode (1972), . 9.

12. Hendin H. et al. Adolescent Marijuana Users and Their Families, Rockville, MD: National Institute on Drug Abuse (1981).

13. Watts W.D., Wright L.S. The Drug Use Violent Delinquency Link Among Adolescent Mexican Americans, pp. 11235 in DeLaRosa M. et. al. (eds) Drugs and Violence: Causes, Correlates, and Consequences, Rockville, MD: National Institute on Drug Abuse (1990);

Abram K.M., Teplin L.A. Drug Disorder, Mental Illness, and Violence, pp. 22238 in Drugs and Violence: Causes, Correlates, and Consequences, Rockville, MD: National Institute on Drug Abuse (1990);

Simonds J.F., Kashani J. Specific Drug Use and Violence in Delinquent Boys, American Journal of Drug and Alcohol Abuse 1: 30522 (1980);

Johnston L.D. et al. (1978), . 9.

14. Spunt B. et al. The Role of Marijuana in Homicide International Journal of the Addictions 29: 195213 (1994).

15. Cherek D.R. et al. Acute Effects of Marijuana Smoking on Aggressive, Escape and Point Maintained Responding of Male Drug Users, Psychopharmacology 111: 16368 (1993).

16. Cherek D.R., Dougherty D.M. Provocation Frequency and its Role in Determining the Effects of Smoked Marijuana on Human Aggressive Responding, Behavioural Pharmacology 6: 40512 (1995);

Cherek D.R., Steinberg J.L. Effects of Drugs on Human Aggressive Behavior, pp. 23990 in Burrows G.D., Werry J.S. (eds) Advances in Human Pgchopharmacology, Vol. IV, Greenwich, CT (1987);

Hollister L.E. et al. Comparison of Tetrahydrocannabinol and Synhexyl in Man, Clinical Pharmacology and Therapeutics 9: 78388 (1968);

Jones R.T., Benowitz N. The 30 Day Trip: Clinical Studies of Cannabis Tolerance and Dependence, pp. 62742 in Braude M.C., Szara S. (eds) Pharmacology of Marihuana, New York: Raven Press (1976);

Mendelson J.H., Meyer R.E. Behavioral and Biological Concomitants of Chronic Marihuana Smoking by Heavy and Chronic Users, pp. 68246 in Marihuana:

Signal of Misunderstanding, Appendix I, Washington, DC: U.S. Government Printing Office (1972).

17. Myerscough R., Taylor S.P. The Effects of Marijuana on Human Physical Aggression, Journal of Personality and Social Psychology 49: 154146 (1985).

18. Ginsberg H.J. et al. Delta 9 Tetrahydrocannabinol Affects Consummatory But Not Appetite Sequence of Interspecific Aggression in the Mongolian Gerbil, Bulletin of the Psychonomic Society 10: 36163 (1977);

Sieber B. et al. Behavioural Effects of Hashish Extract in Mice in Comparison with Other Psychoactive Drugs, General Pharmacology 13:31520 (1982);

Ferraro D.P. Preclinical Effects: Unlearned Behavior, pp. 86102 in Petersen R.C. (ed) Marihuana Research Findings 1976, Rockville, MD: National Institute on Drug Abuse (1977).

19. Carlini E.A. et al. Factors Influencing the Aggressive Behavior Induced by Marihuana in Starved Rats, British Journal of Pharmacology 44: 794804 (1972);

Miczek K.A. et al. Does THC Induce Aggression? Suppression Reactions by Chronic and Acute Delta 9 Tetrahydrocannabinol Treatment in Laboratory Rats, pp. 499514 in Braude M.C., Szara S. (eds) The Pharmacology of Marihuana, New York: Raven Press (1976).

12. , 1. Parents Resource Institute for Drug Education, Marijuana and Cocaine, Atlanta, GA: PRIDE (1990).

2. Center for Substance Abuse Prevention, Female Adolescents and Marijuana Use;

Fact Sheet for Adults, Rockville, MD: U.S. Department of Health and Human Services (1995).

3. Center for Substance Abuse Prevention, Marijuana: Tips for Teens, Rockville, MD: U.S. Department of Health and Human Services (1995).

4. Swan N. A Look at Marijuana's Harmful Effects, NIDA Notes 9, 2 (1994), p. 16.

5. President Bill Clinton, speech at Framingham High School, Framingham, Massachusetts (20 October 1994).

6. Harmon J., Aliapoulios M.A. Gynecomastia in Marijuana Users, New England Journal of Medicine 287:

936 (1972).

7. Cates W., Pope J.N. Gynecomastia and Cannabis Smoking: A Nonassociation Among U.S. Soldiers, American Journal of Surgery 134: 61315 (1977).

8. Kolodny R.C. et al. Plasma Testosterone and Semen Analysis in Male Homosexuals, New England Journal of Medicine 285: 117074 (1971).

9. Kolodny R.C. et al. Depression of Plasma Testosterone Levels After Chronic Intensive Marijuana Use, New England Journal of Medicine 290: 87274 (1974).

10. Kolodny R.C. et al. Depression of Plasma Testosterone with Acute Marihuana Administration, pp. 217 25 in Braude M.C., Szara S. (eds) Pharmacology of Marihuana, New York: Raven Press (1976).

11. Mendelson J.H. et al. Plasma Testosterone Levels Before, During, and After Chronic Marijuana Smoking, New England Journal of Medicine 291: 105155 (1974);

Schaefer C.F. et al. Normal Plasma Testosterone Concentrations After Marijuana Smoking, New England Journal of Medicine 292: 86768 (1975);

Mendelson J.H.

et al. Effects of Chronic Marijuana Use on Integrated Plasma Testosterone and Luteinizing Hormone Levels, Journal of Pharmacology and Experimental Therapeutics 207: 61117 (1978);

Hembree W.C. et al. Marihuana's Effects on Human Gonadal Function, pp. 52132 in Nahas G.G. (ed) Marihuana: Chemistry, Biochemistry, and Cellular Effects, New York: Springer Verlag (1976);

Cone E.J. et al. Acute Effects of Marijuana on Hormones, Subjective Effects and Performance in Male Human Subjects, Pharmacology Biochemistry and Behavior 24: 174954 (1986).

12. Cushman P. Plasma Testosterone Levels in Healthy Male Marijuana Smokers, American Journal of Drug and Alcohol Abuse 2: 26975 (1975);

Block R.I. et al. Effects of Chronic Marijuana Use on Testosterone, Luteinizing Hormone, Follicle Stimulating Hormone, Prolactin and Cortisol in Men and Women, Drug and Alcohol Dependence 28: 12128 (1991);

Coggins W.J. et al. Health Status of Chronic Heavy Cannabis Users, Annals of the New York Academy of Sciences 282: 14861 (1976).

13. Kolodny R.C. et al. (1974), . 9.

14. Chausom A.M., Safer B. Marijuana and Sex, New England Journal of Medicine 291: 308 (1974).

15. Hembree W.C. et al. Changes in Human Spermatozoa Associated with High Dose Marihuana Smoking, pp. 42939 in Nahas G.G., Paton W.D.M. (eds) Marihuana: Biological Effects, Oxford: Pergamon Press (1979).

16. Bauman J. Marijuana and the Female Reproductive System, pp. 8588 in Health Consequences of Marijuana Use, Washington, DC: U.S. Government Printing Office (1980).

138 : 17. Mendelson J.H. et al. Acute Effects of Marijuana Smoking on Prolactin Levels in Human Females, Journal of Pharmacology and Experimental Therapeutics 232: 22022 (1985).

18. Block R.I. et al. (1991), . 12.

19. Harclerode J. Endocrine Effects of Marijuana in the Male: Preclinical Studies, pp. 4664 in Braude M.C., Ludford J.L. (eds) Marijuana Effects on the Endocrine and Reproductive Systems, Rockville, MD: National Institute on Drug Abuse (1984);

Bloch E. Effects of Marijuana and Cannabinoids on Reproduction, Endocrine Function, Development and Chromosomes, pp. 355432 in Fehr K.O., Kalant H. (eds) Cannabis and Health Hazards, Toronto:

Addiction Research Foundation (1983);

Mendelson J.H., Mello N.K. Effects of Marijuana on Neuroendocrine Hormones in Human Males and Females, pp. 97114 in Braude M.C. Ludford J.P. (eds) Marijuana Effects on the Endocrine and Reproductive Systems, Rockville, MD: National Institute on Drug Abuse (1984);

Smith C.G., Asch R.H. Acute, Short Term, and Chronic Effects of Marijuana on the Female Primate Reproductive Function, pp. 82 96 in Braude M.C., Ludford J.P. (eds) Marijuana Effects on the Endocrine and Reproductive Systems, Rockville, MD:

Department of Health and Human Services (1984);

Wenger T. et al. Effects of Delta 9 Tetrahydrocannabinol on Pregnancy, Puberty, and the Neuroendocrine System, pp. 53960 in Murphy L. Bartke A. (eds) Marijuana / Cannabinoids: Neurobiology and Neurophysiology, Boca Raton: CRC Press (1992).

20. Smith C.G. et al. Tolerance Develops to the Disruptive Effects of Delta 9 Tetrahydrocannabinol on the Primate Menstrual Cycle, Science 219: 145355 (1983).

21. Yang Z.M. et al. Activation of Brain Type Cannabinoid Receptors Interferes with Preimplantation Mouse Embryo Development, Biology of Reproduction 55: 75661 (1996).

22. Leshner A. quoted in U.S. Department of Health and Human Services Press Release, Early Pregnancy Halted by Chemicals in Marijuana, Rockville, MD (11 October 1996).

23. Mueller B.A. et al. Recreational Drug Use and the Risk of Primary Infertility, Epidemiology 1: 195 (1990).

24. Wilcox A.J. et al. Risk Factors for Early Pregnancy Loss, Epidemiology 1: 38285 (1990).

25. Abel E.L. Marijuana and Sex: A Critical Survey, Drug and Alcohol Dependence 8;

1 22 (1981);

Ehrenkranz J.R.L., Hembree W.C. Effects of Marijuana on Male Reproductive Function, Psychiatric Annals 16:

24349 (1986).

26. Copeland K.C. et al. Marijuana Smoking and Pubertal Arrest, Journal of Pediatrics 96: 107980 (1980).

27. Wenger T. et al. (1992), . 19;

Smith C.G. Asch R.H. (1984), . 19;

Harclerode J. (1984), .

19.

28. Bauman J. (1980), . 16.

29. Block E. et al. (1991), . 12.

30. Block E. et al. (1991), . 12;

Kolodny R.C. et al. (1974), . 9;

Abel B.A. (1981), . 23.

31. Kolodny R.C. et al. (1976), . 10;

Cone E.J. et al. (1986), . 11.

13. 1. Mann P. The Sad Story of Mary Wanna, NY: Woodmere Press (1988), p. 30.

2. Fried P. quoted in Marijuana: Its Use and Effects, Prevention Pipeline 8, 5 (1995), p. 4.

3. American Council for Drug Education, Drugs and Pregnancy, Rockville, MD (1994).

4. Swan N. A Look at Marijuana's Harmful Effects, NIDA Notes 9, 2: 1415 (1994).

5. Parents Resource Institute for Drug Education, Marijuana Effects on the Female, Atlanta, GA: PRIDE (1996).

6. Hecht F. et al. Lysergic Acid Diethylamide and Cannabis as Possible Teratogens in Man, Lancet 2: (1968);

Carakushansky G. et al. Lysergide and Cannabis as Possible Teratogens in Man, Lancet 1:150 (1969).

7. Maugh T.H. Marihuana: The Grass May No Longer Be Greener, Science 185: 68385 (1974).

8. Matsuyama S., Jarvik L. Effects of Marihuana on the Genetic and Immune Systems, pp. 17993 in Petersen R.C. (ed) Marihuana Research Findings, 1976, Rockville, MD: National Institute on Drug Abuse (1977);

Morishima K. Effects of Cannabis and Natural Cannabinoids on Chromosomes and Ova, pp. 2545 in Braude M.C., Ludford J.L. (eds) Marijuana Effects on the Endocrine and Reproductive Systems, Rockville, MD: National Institute on Drug Abuse (1984).

9. Parents Resource Institute for Drug Education, Marijuana: Effects on the Male, Atlanta, GA: PRIDE (1996);

Spence W.R. Marijuana: Its Effects and Hazards, Waco, TX: Health Edco (undated);

Mann . (1988), . 1.

10. Herclerode J. The Effect of Marijuana on Reproduction and Development, pp. 13766 in Petersen R.C.

(ed) Marijuana Research Findings: 1980, Rockville, MD: National Institute on Drug Abuse (1980);

Abel E.L. Effects of Prenatal Exposure to Cannabinoids, pp. 2035 in Pinkert T.M. (ed) Current Research on the Consequences of Maternal Drug Abuse, Rockville, MD: National Institute on Drug Abuse (1985);

Hutchings D., Dow Edwards D.

Animal Models of Opiate, Cocaine, and Cannabis Use, Clinics in Perinatology 18: 122 (1991);

Behnke M., Eyler F.D. The Consequences of Prenatal Substance Use for the Developing Fetus, Newborn, and Young Child, International Journal of the Addictions 28: 134191 (1993);

Wenger T. et al. Effects of Delta Tetrahydrocannabinol on Pregnancy, Puberty, and the Neuroendocrine System, pp. 53960 in Murphy L. Bartke A. (eds) Marijuana / Cannabinoids: Neurobiology and Neurophysiology, Boca Raton, FL: CRC Press (1992).

11. Rudolph A.M. Animal Models for Study of Fetal Drug Exposure, pp. 516 in Chiang C.N., Lee C.C. (eds) Prenatal Drug Exposure: Kinetics and Dynamics, Rockville, MD: National Institute on Drug Abuse (1985).

12. Fried P.A. Postnatal Consequences of Maternal Marijuana Use, pp. 6172 in Pinkert T.M. (ed) Current Research on the Consequences of Maternal Drug Abuse, Rockville, MD: National Institute on Drug Abuse (1985);

Golub M.S. et al. Peer and Maternal Social Interaction Patterns in Offspring of Rhesus Monkeys Treated Chronically with Delta 9 Tetrahydrocannabinol, pp. 65767 in Agurell S. The Cannabinoids: Chemical, Pharmacological, and Therapeutic Aspects, Orlando: Academic Press (1984);

Herclerode I. (1980), . 10.

13. Grilly D.M. et al. Observations on the Reproductive Activity of Chimpanzees Following Long Term Exposure to Marijuana, Pharmacology 11: 30407 (1974).

14. Linn S. et al. The Association of Marijuana Use with Outcome of Pregnancy, American Journal of Public Health 73:116164 (1983).

15. Shiono P.H. et al. The Impact of Cocaine and Marijuana Use on Low Birth Weight and Preterm Birth: A Multicenter Study, American Journal of Obstetrics and Gynecology 172: 1927 (1995);

Knight E.M. et al.

Relationships of Serum Illicit Drug Concentrations During Pregnancy to Maternal Nutritional Status, Journal of Nutrition 124: 97380S (1994);

Tennes K. Blackard C. Maternal Alcohol Consumption, Birthweight, and Minor Physical Abnormalities, American Journal of Obstetrics and Gynecology 138: 77480 (1980);

Hayes J. et al.

Newborn Outcomes with Maternal Marijuana Use in Jamaican Women, Pediatric Nursing 14:10710 (1988);

Fried P.A., O'Connell C.M. A Comparison of the Effects of Prenatal Exposure to Tobacco, Alcohol, Cannabis and Caffeine on Birth Size and Subsequent Growth, Neurotoxicology and Teratology 9: 7985 (1987);

O'Connell C.M., Fried P.A. An Investigation of Prenatal Cannabis Exposure and Minor Physical Anomalies in a Low Risk Population, Neurobehavioral Toxicology and Teratology 6: 34550 (1984);

Richardson G.A. et al. The Effect of Prenatal Alcohol, Marijuana and Tobacco Exposure on Neonatal Behavior, Infant Behavioral Development 12: 199 (1989);

Astley S. Analysis of Facial Shape in Children Gestationally Exposed to Marijuana, Alcohol, and / or Cocaine, Pediatrics 89: 6777 (1992);

Witter F.R., Niebyl J.R. Marijuana Use in Pregnancy and Pregnancy Outcome, American Journal of Perinatology 7: 3638 (1990).

16. Dreher M.C. et al. Prenatal Exposure and Neonatal Outcomes in Jamaica: An Ethnographic Study, Pediatrics 93: 25460 (1994);

Tennes K. et al. Marijuana: Prenatal and Postnatal Exposure in the Human, pp.

4860 in Pinkert T.M. (ed) Current Research on the Consequences of Maternal Drug Abuse, Rockville, MD: National Institute on Drug Abuse (1985).

17. Hatch E.E., Braken M.B. Effect of Marijuana Use in Pregnancy on Fetal Growth, American Journal of Epidemiology 124: 98693 (1986);

Kline J. et al. Cigarettes, Alcohol and Marijuana: Varying Associations with Birthweight, International Journal of Epidemiology 16: 4451 (1987);

Zuckerman B. et al. Effects of Maternal Marijuana and Cocaine Use on Fetal Growth, New England Journal of Medicine 320: 76268 (1989);

Fried P.A.

et al. Marijuana Use During Pregnancy and Decreased Length of Gestation, American Journal of Obstetrics and Gynecology 150:2326 (1984);

Hingson R. et al. Effects of Maternal Drinking and Marijuana Use on Petal Growth and Development, Pediatrics 70: 53946 (1982);

Fried P.A., Makin J.E. Neonatal Behavioral Correlates of Prenatal Exposure to Marijuana, Cigarettes and Alcohol in a Low Risk Population, Neurotoxicology and Teratology 9: 17 (1987);

Cornelius M.D. et al. Prenatal Tobacco and Marijuana Use Among Adolescents: Effects on Offspring Gestational Age, Growth, and Morphology, Pediatrics 95: 73843 (1995);

Day N. et al. Prenatal Marijuana Use and Neonatal Outcome, Neurotoxicology and Teratology 13: 32934 (1991).

18. Day N.L., Richardson G.A. Prenatal Marijuana Use: Epidemiology Methodologic Issues, and Infant Outcome, Clinics in Perinatology 18: 7791 (1991);

Richardson G.A. et al. The Impact of Marijuana and Cocaine Use on the Infant and Child, Clinical Obstetrics and Gynecology 36: 30218 (1993);

Cornelius M.D. et al. (1995), 140 : . 17;

Coles C.D. et al. Effects of Cocaine, Alcohol, and Other Drug Use in Pregnancy on Neonatal Growth and Neurobehavioral Status, Neurotoxicology and Teratology 14: 2233 (1992).

19. Day N.L. et al. (1991), . 17.

20. Hatch E.E., Bracken M.B. (1986), . 17.

21. Fried P.A. et al. (1984), . 17.

22. Tennes K. et al. (1985), . 16.

23. Day N.L. et al. Effect of Prenatal Marijuana Exposure on the Cognitive Development of Offspring at Age Three, Neurotoxicology and Teratology 16: 16975 (1994).

24. Streissguth A.P. et al. IQ at Age 4 in Relation to Maternal Alcohol Use and Smoking During Pregnancy, Developmental Psychology 25: 311 (1989).

25. Day N.L. et al. (1994), . 23.

26. Center on Addiction and Substance Abuse, Legalization: Panacea or Pandora's Box, New York (1995);

Drug Watch Oregon, Marijuana Research Review 2, 4 (1995).

27. Robison L.L. et al. Maternal Drug Use and Risk of Non Lymphoblastic Leukemia Among Offspring, Cancer 63: 190411 (1989).

28. Grufferman S. et al. Parents' Use of Cocaine and Marijuana and Increased Risk of Rhabdomyosarcoma in Their Children, Cancer Causes and Control 4: 21724 (1993).

29. Day N.L. et al. The Epidemiology of Alcohol, Marijuana and Cocaine Use Among Women of Childbearing Age and Pregnant Women, Clinical Obstetrics and Gynecology 36: 23245 (1993).

30. Grufferman S. et al. Environmental Factors in the Etiology of Rhabdomyosarcoma in Childhood, Journal of the National Cancer Institute 68: 10713 (1982).

31. National Toxicology Program, Toxicology and Carcinogenesis: Studies of 1 Trans Delta Tetrahydrocannabinol in F344/N Rats and B6c3F1 Mice, Rockville, MD: U.S. Department of Health and Human Services (1996).

32. Fried P.A., Watkinson B. 12 and 24 Month Neurobehavioral Follow Up of Children Prenatally Exposed to Marijuana, Cigarettes and Alcohol, Neurotoxicology and Teratology 10: 30513 (1988).

33. Fried P.A., Watkinson B. 36 and 48 Month Neurobehavioral Follow Up of Children Prenatally Exposed to Marijuana, Cigarettes, and Alcohol, Developmental and Behavioral Pediatrics 11: 4958 (1990).

34. Fried P.A., Watkinson B. (1990), . 33.

35. Fried P.A. et al. 60 and 72 Month Follow Up of Children Prenatally Exposed to Marijuana, Cigarettes, and Alcohol: Cognitive and Language Assessment, Journal of Developmental and Behavioral Pediatrics 13: 383 91 (1992).

36. Fried P.A. et al. A Follow Up Study of Attentional Behavior in 6 Year Old Children Exposed Prenatally to Marijuana, Cigarettes, and Alcohol, Neurotoxicology and Teratology 14: 299311 (1992).

37. O'Connell C.M., Fried P.A. Prenatal Exposure to Cannabis: A Preliminary Report of Postnatal Consequences in School Age Children, Neurotoxicology and Teratology 13: 63139 (1991).

38. Fried P.A. Prenatal Exposure to Marijuana and Tobacco During Infancy, Early and Middle Childhood:

Effects and Attempts at a Synthesis, Archives of Toxicology 17: 240241 (1995).

39. Fried P.A. The Ottawa Prenatal Prospective Study (OPPS): Methodological Issues and Findings It's Easy to Throw the Baby Out With the Bath Water, Life Sciences 56: 215968 (1995).

40. National Conference on Marijuana Use: Prevention, Treatment, and Research, sponsored by the National Institute on Drug Abuse, Arlington, VA (July 1995).

41. Center for Substance Abuse Prevention, Marijuana: Its Uses and Effects, Prevention Pipeline 8, 5: 3 (1995).

42. Fried P.A. Prenatal Exposure to Tobacco and Marijuana: Effects During Pregnancy, Infancy, and Early Childhood, Clinical Obstetrics and Gynecology 36: 31937 (1993).

43. Fried P.A. (1993), . 42.

44. Fried P.A. Cigarettes and Marijuana: Are There Measurable Long Term Neurobehavioral Teratogenic Effects?, Neurotoxicology 10: 57784 (1989);

Day N. et al. The Effects of Prenatal Tobacco and Marijuana Use on Offspring Growth From Birth Through 3 Years of Age, Neurotoxicology and Teratology 14: 40714 (1992);

Barr H.M. et al. Infant Size at 8 Months of Age: Relationship to Maternal Use of Alcohol, Nicotine, and Caffeine During Pregnancy, Pediatrics 74: 33641 (1984);

Fried P.A., Watkinson B. (1990), . 31;

Streissguth A.P.

et al. (1989), . 24;

Cornelius M.D. et al. (1990), . 17;

Kline J. et al. (1987), . 17;

Pried P.A. (1995), . 38.

14. 1. Parents Resource Institute for Drug Education, Marijuana and Cocaine, Atlanta: PRIDE (1990).

2. Ernest D. Preate, Blowing Away the Marijuana Smokescreen, Scranton: Pennsylvania Office of Attorney General (no date), p. 2.

3. Spence W.R. Marijuana: Its Effects and Hazards, Waco: Health Edco (no date).

4. Voth E.A. The International Drug Strategy Institute Position Paper on the Medical Applications of Marijuana, Omaha: Drug Watch International (undated).

5. Drug Watch International, By Any Modern Medical Standard, Marijuana is No Medicine, Omaha (undated).

6. Nahas G.G. Marihuana Deceptive Weed, New York: Raven Press (1973).

7. Nahas G.G. Keep Off the Grass, New York: Reader's Digest Press (1976).

8. Nahas G.G. et al. Inhibition of Cellular Mediated Immunity in Marihuana Smokers, Science 183: 41920 (1974).

9. Nahas G.G. (1976), . 7.

10. Lau R.J. et al. Phytohemagglutinin Induced Lymphocyte Transformation in Humans Receiving Delta Tetrahydrocannabinol, Science 192: 80507 (1976);

White S.C. et al. Mitogen Induced Blastogenetic Responses to Lymphocytes from Marihuana Smokers, Science 188: 7172 (1975);

Dax E.M. et al. The Effects of 9 ENE Tetrahydrocannabinol on Hormone Release and Immune Function, Journal of Steroid Biochemistry 34: 263 (1989);

Kaklamani E. et al. Hashish Smoking and T Lymphocytes, Archives of Toxicology 40: 97101 (1978).

11. Nahas G.G. Keep Off the Grass, 5th edition, Middlebury, VT: Eriksson P.S. (1990).

12. Hollister L.E. Marijuana and Immunity, Journal of Psychoactive Drugs 24:15964 (1992).

13. Holsapple M.P. et al. Molecular Mechanisms of Toxicant Induced Immuno suppression: Role of Second Messengers, Annual Review of Pharmacology and Toxicology 36: 13159 (1996);

Spector S. et al. Delta Tetrahydrocannabinol Augments Murine Retroviral Induced Immunosuppression and Infection, International Journal of Immunopharmacology 13: 41117 (1991);

Klein T.W. et al. The Effect of Delta 9 Tetrahydrocannabinol and 11 Hydroxy Delta 9 Tetrahydrocannabinol on T Lymphocyte and B Lymphocyte Mitogen Responses, Journal of Immunopharmacology 1: 45166 (1985);

Nahas G.G. et al. Natural Cannabinoids: Apparent Depression of Nucleic Acids and Protein Synthesis in Cultured Human Lymphocytes, pp. 177203 in Braude M.C., Szara S. (eds) Pharmacology of Marihuana, New York: Raven Press (1976);

Watzl B. et al. Influence of Marijuana Components (THC and CBD) on Human Mono nuclear Cell Cytokine Secretion In Vitro, pp. 6370 in Friedman H. et al. (eds) Drugs of Abuse, Immunity, and Immunodeficiency, New York: Plenum Press (1991).

14. Banchereau J et al. Inhibitory Effects of Delta 9 Tetrahydrocannabinol and Other Psychotropic Drugs on Cultured Lymphocytes, pp. 12944 in Nahas G.G. Paton W.D.M. (eds) Marihuana: Biological Effects, New York:

Pergamon Press (1979);

Nahas G.G. et al. (1976), . 13.

15. Munson A.E., Fehr K.O. Immunological Effects of Cannabis, pp. 257353 in Fehr K.O. Kalant H. (eds) Cannabis and Health Hazards, Toronto: Addiction Research Foundation (1983).

16. Cabral G.A. et al. Effect of Delta 9 Tetrahydrocannabinol on Herpes Simplex Virus Type 2 Vaginal Infection in the Guinea Pig, Proceedings of the Society for Experimental Biology and Medicine 182: 18186 (1986).

17. Mishkin E.M., Cabral G.A. Delta 9 Tetrahydrocannabinol Decreases Host Resistance to Herpes Simplex Virus Type 2 Vaginal Infection in the BGC3F1 Mouse, Journal of General Virology 66: 253949 (1985).

18. Silverstein M.J., Lensin P. 2, 4 Dinitrochlorobenzene Skin Testing in Chronic Marihuana Users, pp.

199203 in Braude M.C. Szara S. (eds) Pharmacology of Marihuana, New York: Raven Press (1976).

19. Munson A.E., Fehr K.O. (1983), . 15, p. 338.

20. Marinol, pp. 212931 in Physician's Desk Reference, Forty Ninth Edition, Montvale, NJ: Medical Economics (1995).

21. Food and Drug Administration, Unimed's Marinol (Dronabinol) Gains Indication for Anorexia in AIDS Patients, Food, Drug, and Cosmetic Reporter. 14 (4 January 1993).

142 : 22. Huber G.L. et al. Marijuana: Tetrahydrocannabinol and Pulmonary Antibacterial Defenses, Chest 77:

40310 (1980).

23. Cabral G.A. et al. Chronic Marijuana Smoke Alters Alveolar Macrophage Morphology and Protein Expression, Pharmacology Biochemistry and Behavior 40: 64350 (1991).

24. Barbers R.G. et al. Enhanced Alveolar Monocytic Phagocyte (Macrophage) Proliferation in Tobacco and Marijuana Smokers, American Review of Respiratory Disease 143: 109295 (1991);

Barbers R.G. et al. Differential Examination of Bronchoalveolar Lavage Cells in Tobacco and Marijuana Smokers, American Review of Respiratory Disease 135: 127175 (1987).

25. Wallace J.M. et al. Lymphocytic Subpopulation Profiles in Bronchoalveolar Lavage Fluid and Peripheral Blood from Tobacco and Marijuana Smokers, Chest 105: 84752 (1994);

Sherman M.P. et al. Marijuana Smoking, Pulmonary Function, and Lung Macrophage Oxidant Release, Pharmacology Biochemistry and Behavior 40: 663 69 (1991);

Sherman M.P. et al. Effects of Smoking Marijuana, Tobacco or Cocaine Alone or in Combination on DNA Damage in Human Alveolar Macrophages, Life Sciences 56: 220107 (1995).

26. Nieman R.B. et al. The Effect of Cigarette Smoking on the Development of AIDS in HIV 1 Seropositive Individuals, AIDS 7: 70510 (1993);

Bushkin S.E. et al. Heavy Smoking Increases the Risk of Pneumocystis Carinii Pneumonia (PCP), paper presented at the International Conference on AIDS, Amsterdam (1992).

27. Caiaffa W.T. et al. Drug Smoking, Pneumocystis Carinii Pneumonia, and Immunosuppression Increase Risk of Bacterial Pneumonia in Human Immunodeficiency Virus Seropositive Injection Drug Users, American Journal of Respiratory and Critical Care Medicine 150: 149398 (1994).

28. Coates R.A. et al. Cofactors of Progression to Acquired Immunodeficiency Syndrome in a Cohort of Male Sexual Contacts of Men with Immunodeficiency Virus Disease, American Journal of Epidemiology 132: 717 (1990);

Kaslow R.A. et al. No Evidence for a Role of Alcohol or Other Psychoactive Drugs in Accelerating Immunodeficiency in HIV 1 Positive Individuals, Journal of the American Medical Association 261: 342429 (1989).

29. McCaffery B. remarks on C SPAN (21 December,1996);

Drug Enforcement Administration, Drug Legalization: Myths and Misconceptions, Washington, DC (1994);

Gorman T.J. Marijuana is NOT a Medicine, Santa Clarita, CA: California Narcotics Officers' Association (1996);

Drug Watch International, By Any Modern Medical Standard, Marijuana is No Medicine, Omaha (undated);

Drug Watch Oregon, Marijuana Research Review (February 1994);

Peterson R.E. The Marijuana as Medicine Scam, Lansing, MI: Michigan Office of Drug Control Policy (undated).

30. Chusid M. J. et al. Pulmonary Aspergillosis, Inhalation of Contaminated Marijuana Smoke, Chronic Granulomatous Disease, Annals of Internal Medicine 82: 68283 (1975).

31. Sutton S. et al. Possible Risk of Invasive Pulmonary Aspergillosis with Marijuana Use During Chemotherapy for Small Cell Lung Cancer, Drug Intelligence and Clinical Pharmacology 20: 28990 (1986);

Denning D.W. et al.

Pulmonary Aspergillosis in the Acquired Immunodeficiency Syndrome, New England Journal of Medicine 324:

65462 (1991).

15. 1. Center on Addiction and Substance Abuse, Legalization: Panacea or Pandora's Box, New York (1995), p. 36.

2. Turner C.E. The Marijuana Controversy, Rockville, MD: American Council for Drug Education (1981).

3. Nahas G.G., Pace N.A. Marijuana as Chemotherapy Aid Poses Hazards, letter to the editor, New York Times (4 December 1993), p. 20.

4. Inaba D.S., Cohen D.E. Uppers, Downers, All Arounders: Physical and Mental Effects of Psychoactive Drugs, 2nd Edition, Ashland, OR: CNS Productions, Inc. (1995), p. 174.

5. Tomatis L. (ed), Cancer: Causes, Occurrence and Control, Lyon: International Agency on Cancer (1990);

Department of Health and Human Services, The Health Consequences of Smoking: Chronic Obstructive Lung Disease, Washington, DC: U.S. Government Printing Office (1984).

6. Huber G.L. et al. Marijuana and Tobacco Smoke: Gas Phase Cytoxins, Pharmacology Biochemistry and Behavior 40: 62936 (1991).

7. Wu T. et al. Pulmonary Hazards of Smoking Marijuana as Compared with Tobacco, New England Journal of Medicine 318: 34751 (1988).

8. Tashkin D.P. et al. Effects of Habitual Use of Marijuana and / or Cocaine on the Lung, pp. 6387 in Chiang N. Hawkins R.L. (eds) Research Findings on Smoking of Abused Substances, Rockville, MD: National Institute on Drug Abuse (1990);

Sherrill D.L. et al. Respiratory Effects of Non Tobacco Cigarettes: A Longitudinal Study in the General Population, International Journal of Epidemiology 20: 13237 (1991).

9. Polen M.R. Health Care Use by Frequent Marijuana Smokers Who Do Not Smoke Tobacco, Western Journal of Medicine 158: 596601 (1993).

10. Tashkin D. quoted in Gagnon L. Marijuana Less Harmful to Lungs than Cigarettes, Medical Post (Quebec) (6 September 1994).

11. Tashkin D.P. Heavy Habitual Marijuana Smoking Does Not Cause an Accelerated Decline in FEV1 With Age, American Journal of Respiratory and Critical Care Medicine 155: 14148 (1997).

12. Didcott P. et al. Long Term Cannabis Users on the New South Wales North Cost, Canberra: Australian Government Publishing Service (1997).

13. Glatt H. et al. Delta 1 Tetrahydrocannabinol and 1 Alpha, 2 Alpha Epoxyhexahydrocannabinol:

Mutagenicity Investigation in the Ames Test, Mutation Research 66: 32935 (1979);

Zimmerman S., Zimmerman A.M. Genetic Effects of Marijuana, International Journal of the Addictions 25:1933 (199091).

14. Leuchtenberger C. Effects of Marijuana (Cannabis) Smoke on Cellular Biochemistry of In VitroTest Systems, pp. 177224 in Fehr K.O. Kalant K. (eds) Cannabis and Health Hazards, Toronto: Addiction Research Foundation (1983).

15. Novotny M. et al. Possible Basis for the Higher Mutagenicity of Marijuana Smoke as Compared to Tobacco Smoke, Experientia 32: 28082 (1975);

Hoffman D. et al. On the Carcinogenicity of Marijuana Smoke, Recent Advances in Photochemistry 9: 6381 (1975).

16. Harvey R.G. Polycyclic Aromatic Hydrocarbons: Chemistry and Carcinogenicity, Cambridge: Oxford University Press (1991).

17. Huber G.L. et al. The Effects of Marijuana on the Respiratory and Cardiovascular Systems, pp. 318 in Chesher G. et al. (eds) Marijuana: an International Research Report, Canberra: Australian Government Publishing Service (1988).

18. Fligiel S.E.G. et al. Bronchial Pathology in Chronic Marijuana Smokers: A Light Electron Microscope Study, Journal of Psychoactive Drugs 20: 3342 (1988).

19. Fligiel S.E.G. et al. Pulmonary Pathology in Marijuana Smokers, pp. 4347 in Chesher G. et al. (eds) Marijuana: An International Research Report, Canberra: Australian Government Publishing Service (1988).

20. Sridhar K. et al. Possible Role of Marijuana Smoking as a Carcinogen in the Development of Lung Cancer at a Young Age, Journal of Psychoactive Drugs 26: 28588 (1994).

21. Substance Abuse and Mental Health Services Administration, National Household Survey on Drug Abuse:

Main Findings 1994, Rockville, MD: U.S. Department of Health and Human Services (1996), pp. 46, 49.

22. Doblin R. The MAPS / California NORML Marijuana Waterpipe / Vaporizer Study, Newsletter of the Multidisciplinary Association for Psychedelic Studies 5, 1: 1922 (1994).

23. Agurell S., Leander K. Stability, Transfer and Aborption of Cannabinoid Constituents of Cannabis (Hashish) Smoking, Acta Pharmaceutica Suecica 8: 391402 (1971);

Zacny J.P., Chait L.D. Breathhold Duration and Response to Marijuana Smoke, Pharmacology Biochemistry and Behavior 33: 48184 (1989);

Zorilosa J. et al.

Marijuana Smoking: Effects of Varying Puff Volumes and Breathholding Duration, Journal of Pharmacology and Experimental Therapeutics 272: 56069 (1995).

16. 1. Committees of Correspondence, Drug Abuse Newsletter16 (March 1984).

2. Mann P. Marijuana Alert, New York: McGraw Hill Book Company (1985), p. 184.

3. Nahas G.G. When Friends or Patients Ask About Marihuana, Journal of the American Medical Association 233 (1979), p. 79.

4. DuPont R. Getting Tough on Gateway Drugs, Washington, DC: American Psychiatric Press, Inc. (1984), p. 68.

5. Martin B.R. Cellular Effects of Cannabinoids, Pharmacological Reviews 38: 4574 (1986).

6. Agurell S. et al. Pharmacokinetics and Metabolism of Delta 1 Tetrahydrocannabinol and Other Cannabinoids with Emphasis on Man, Pharmacological Reviews 38: 2143 (1986);

Cone E.J. et al. Acute Effects of Smoking Marijuana on Hormones, Subjective Effects and Performance in Male Human Subjects, Pharmacology Biochemistry and Behavior 24: 174954 (1986).

144 : 7. Barnett G. et al. Behavioral Pharmacokinetics of Marijuana, Psychopharmacology 85: 5156 (1985);

Cone E.J., Huestis M.A. Relating Blood Concentrations of Tetrahydrocannabinol and Metabolites to Pharmacologic Effects and Time of Marijuana Usage, Therapeutic Drug Monitoring 15: 52732 (1993);

Morgan J.P. Marijuana Metabolism in the Context of Urine Testing for Cannabinoid Metabolite, Journal of Psychoactive Drugs 20: 107 15 (1988).

8. Swatek, R. Marijuana Use: Persistence and Urinary Elimination, Journal of Substance Abuse Treatment 1:

26570 (1984).

9. Garrett E.R. Pharmacokinetics and Disposition of Delta 9 Tetrahydrocannabinol and its Metabolites, Advances in Bioscience 2223:10521 (1978).

10. Hollister L.E. Health Aspects of Cannabis, Pharmacological Reviews 38:120 (1986).

11. Moscowitz H. et al. Duration of Skills Performance Impairment Under Marijuana, American Association for Automotive Medicine Proceedings 181: 8796 (1979);

Chait L.D. et al. 'Hangover' Effects The Morning After Marijuana Smoking, Drug and Alcohol Dependence 15: 22938 (1985);

Yesavage J.A. et al. Carry Over Effects of Marijuana Intoxication on Aircraft Pilot Performance: A Preliminary Report, American Journal of Psychiatry 142:132529 (1985);

Leirer V.O. et al. Marijuana Carry Over Effects on Aircraft Pilot Performance, Aviation, Space, and Environmental Medicine 62: 22127 (1991).

12. Chait L.D. Subjective and Behavioral Effects of Marijuana the Morning After, Psychopharmacology 100:

32833 (1990);

Cocchetto D.M. et al. Relationship Between Plasma Delta 9 Tetrahydrocannabinol Concentration and Pharmacologic Effects in Man, Psychopharmacology 75:15864 (1981);

Hollister L.E. et al. Do Plasma Concentrations of Delta 9 Tetrahydrocannabinol Reflect the Degree of Intoxication?, Journal of Clinical Pharmacology 21:17177S (1981);

Lindgren J.C. et al. Clinical Effects and Plasma Levels of Delta 9 Tetrahydrocannabinol (Delta 9 THC) in Heavy and Light Users of Cannabis, Psychopharmacology 74: 80212 (1981);

Perez Reyes M.

et al. The Clinical Pharmacology and Dynamics of Marijuana Cigarette Smoking, Journal of Clinical Pharmacology 21: 20107S (1981);

Perez Reyes M. et al. Comparison of Effects of Marijuana Cigarettes of Three Different Potencies, Clinical Pharmacology and Therapeutics 31: 61724 (1982);

Ohlsson A. et al. Plasma Delta Tetrahydrocannabinol Concentrations and Clinical Effects After Oral and Intravenous Administration and Smoking, Clinical Pharmacology and Therapeutics 28: 40916 (1980);

Leirer V.O. et al. Marijuana, Aging, and Task Difficult Effects on Pilot Performance, Aviation, Space, and Environmental Medicine 60:114552 (1989);

Janowsky D.S.

et al. Marijuana Effects on Simulated Flying Ability, American Journal of Psychiatry 133: 38488 (1976);

Cone E.I.

et al. (1986), . 6.

13. Hollister L.E. (1986), . 10.

14. Kreuz D.S., Axelrod J. Delta 9 Tetrahydrocannabinol: Localization in Body Fat, Science 179: 391 (1973);

Johansson E. et al. Analysis of Delta 1 Tetrahydrocannabinol (Delta 1 THC) in Human Plasma and Fat After Smoking, pp. 29196 in Chesher E. et al. (eds) Marijuana: An International Report, Canberra: Australian Government Publishing Service (1988).

15. Siegel G.J. et al. Basic Neurochemistry, New York: Raven Press (1989).

16. Ryrfeldt A. Whole Body Autoradiography of Delta 1 Tetrahydrocannabinol and Delta 6 Tetra hydrocannabinol in Mouse, Acta Pharmaceutica Suecica 10: 1328 (1973);

Nahas G. et al. The Kinetics of Cannabinoid Distribution and Storage with Special Reference to the Brain and Testes, Journal of Clinical Pharmacology 21: 20814S (1981);

Bronson M. et al. Distribution and Disposition of Delta 9 Tetrahydrocannabinol (THC) in Different Tissues of the Rat, pp. 30917 in Agurell S. et al. (eds) The Cannabinoids: Chemical, Pharmacologic, and Therapeutic Aspects, Orlando: Academic Press (1984);

Kreuz D.S., Axelrod J. (1973) . 14.

17. Hollister L.E. (1986), . 10.

18. Morgan J.P. Urine Testing for Cannabinoid Metabolite;

Technical and Practical Problems, pp. 333 in Chesher G. et al. (eds) Marijuana: An International Report, Canberra: Australian Government Publishing Service (1988).

17. 1. Center on Addiction and Substance Abuse, Legalization: Panacea or Pandora's Box, New York (1995), p. 36.

2. Neil Swan, A Look at Marijuana's Harmful Effects, NIDA Notes 9, 2 (1994), p. 14.

3. Moskowitz H., Petersen R. Marijuana and Driving: A Review, Rockville, MD: American Council for Drug Education (1982), p. 7.

4. Mann P. Marijuana Alert, New York: McGraw Hill (1985), p. 265.

5. Jacobs J.B. Drunk Driving: An American Dilemma, Chicago: University of Chicago Press (1989).

6. National Commission on Marihuana and Drug Abuse, Marihuana: A Signal of Misunderstanding, Washington, DC: U.S. Government Printing Office (1972).

7. Robbe H., O'Hanlon J. Marijuana and Actual Driving Performance, Washington, DC: Department of Transportation (1993), p. 107.

8. Moskowitz H. Marijuana and Driving, Accident Analysis and Prevention 17: 32345 (1985).

9. Stein A.C. et al. A Simulator Study of the Combined Effects of Alcohol and Marijuana on Driving Behavior;

Phase II, Washington, DC: U.S. Department of Transportation (1983);

Hansteen R.W. et al. Effects of Cannabis and Alcohol on Automobile Driving and Psychomotor Tracking, Annals of New York Academy of Sciences 282:

24056 (1976);

Moskowitz H. et al. Marihuana: Effects on Simulated Driving Performance, Accident Analysis and Prevention 8:4550 (1976);

Crancer A. et al. Comparison of the Effects of Marihuana and Alcohol on Simulated Driving Performance, Science 164: 85154 (1969).

10. Klonoff H. Marijuana and Driving in Real Life Situations, Science 186: 31724 (1974);

Sutton L.R. The Effects of Alcohol, Marijuana and Their Combination on Driving Ability, Journal of Studies on Alcohol 44: 438 (1983);

Peck R.C. et al. The Effects of Marijuana and Alcohol on Actual Driving Performance, Alcohol, Drugs and Driving 2: 13554 (1986);

Hansteen R.W. et. al. (1976), . 9.

11. Smiley A. Marijuana: On Road and Driving Simulator Studies, Alcohol, Drugs and Driving 2: 121 (1986);

Chesher G.B. Cannabis and Road Safety: An Outline of the Research Studies to Examine the Effects of Cannabis on Driving Skills and On Actual Driving Performance, pp. 6796 in Inquiry into the Effects of Drugs (Other than Alcohol) on Road Safely in Victoria, Report of the Parliament of Victoria, Melbourne: Government Printer (1995);

Dott A.B. Effect of Marihuana on Risk Acceptance in a Simulated Passing Task, Rockville, MD: U.S.

Department of Health, Education, and Welfare (1972);

Moskowitz H. (1985), . 8.

12. Robbe H., O'Hanlon J. (1993), . 7.

13. Mathias R. Marijuana Impairs Driving Related Skills and Workplace Performance, NIDA Notes 11,1: 6 (1996).

14. Moskowitz H., McGlothlin W. Effects of Marihuana on Auditory Signal Detection, Psychopharmacology 40: 13740 (1974);

Moskowitz H. et al. (1976), . 9.

15. Barnett G. et al. Behavioral Pharmacokinetics of Marijuana, Psychopharmacology 85: 5156 (1985);

Smiley A. (1986), . 11.

16. Martin B.R. Cellular Effects of Cannabinoids, Pharmacological Reviews 38: 4574 (1986).

17. McBay A.J., Owens S.M. Marijuana and Driving, pp. 25763 in Harris L.S. (ed) Problems of Drug Dependence 1980, Washington, DC: U.S. Government Printing Office (1981);

Terhune K.W. et al. The Incidence and Role of Drugs in Fatally Injured Drivers, Washington, DC: Department of Transportation (1992);

Cimbura G. et al. Incidence and Toxicological Aspects of Drugs Detected in 484 Fatally Injured Drivers and Pedestrians in Canada, Journal of Forensic Sciences 27: 85567 (1982);

Mason A.P, McBay AJ. Ethanol, Marijuana, and Other Drug Use in 600 Drivers Killed in SingleVehicular Crashes in North Carolina, Journal of Forensic Sciences 29: 987 (1984);

Crouch D.J. et al. The Prevalence of Drugs and Alcohol in Fatally Injured Truck Drivers, Journal of Forensic Sciences 38: 134253 (1993);

Drummer O.H. A Review of the Contribution of Drugs in Drivers to Road Accidents, pp. 128 in Inquiry into the Effects of Drugs (Other than Alcohol) on Road Safety in Victoria, Report of the Parliament of Victoria, Melbourne: Government Printer (1995);

Cimbura G. et al. Incidence and Toxicological Aspects of Cannabis and Ethanol in 1394 Fatally Injured Drivers and Pedestrians in Ontario (19821984), Journal of Forensic Sciences 35: 103541 (1990).

18. Terhune K. The Role of Alcohol, Marijuana and Other Drugs in the Accidents of Injured Drivers, Washington, DC: Department of Transportation (1982).

19. Williams A. et al. Drugs in Fatally Injured Young Male Drivers, Public Health Reports 100: 19 (1985);

Terhune K.W. et al. (1992), . 17;

Drummer O.H. (1995), . 17.

20. Drummer O.H. (1995), . 17, p 13.

21. Chait L.D, Pierri J. Effects of Smoked Marijuana on Human Performance: A Critical Review, pp. 387 424 in Murphy L, Bartke A. (eds) Marijuana / Cannabinoids: Neurobiology and Neurophysiology, Boca Raton: CRC Press (1992).

22. Ellingstad, V.S. et al. Alcohol, Marihuana, and Risk Taking, Washington, DC: National Highway Traffic Safety Administration (1973);

Stein A.C. et al. (1983), . 9;

Dott A.B. (1972), . 11.

146 : 23. Cappell H.D, Pliner P.L. Volitional Control of Marijuana Intoxication: A Study of the Ability to 'Come Down' on Command, Journal of Abnormal Psychology 82: 42834 (1973);

Smiley A. (1986), . 11.

24. Mayhew D.R. et al. Alcohol and Cannabis Among Fatally Injured Motorcyclists, pp. 26770 in Noordzj P.C. et al. (eds) Alcohol, Drugs and Traffic Safety, Amsterdam: Excerpta Medica (1987);

Soderstrom C.A. et al.

Marijuana and Alcohol Use Among 1,023 Trauma Patients, Archives of Surgery 123: 73337 (1988);

Soderstrom C.A. et al. Marijuana and Other Drug Use Among Automobile and Motorcycle Drivers Treated at a Trauma Center, Accident Analysis and Prevention 27: 13135 (1995).

25. Brookoff D. et al. Testing Reckless Drivers for Cocaine and Marijuana, New England Journal of Medicine 331: 51822 (1994).

26. Johnson V., White H.R. An Investigation of Factors Related to Intoxicated Driving Behaviors Among Youth, Journal of Studies on Alcohol 50: 32030 (1989).

27. Reeve V.C. et al. Hemolyzed Blood and Serum Levels of Delta 9 THC: Effects on the Performance of Roadside Sobriety Tests, Journal of Forensic Sciences 28: 96371 (1983);

Cocchetto, D.M. Relationship Between Plasma Delta 9 Tetrahydrocannabinol Concentration and Pharmacologic Effects in Man, Psychopharmacology 75:

15864 (1981);

Chesher G.B. (1995), . 11.

28. Page T.E. The Drug Recognition Expert Response, pp. 12147 in Inquiry in the Effects of Drugs (Other than Alcohol) on Road Safety in Victoria, Report of the Parliament of Victoria, Melbourne: Government Printer (1995);

Brookoff D. et al. (1994), . 25.

18. , 1. Brown L. Director of National Drug Control Policy, quoted in U.S. Department of Health and Human Services Press Release, National Drug Survey Results Released with New Youth Public Education Materials, Rockville, MD (12 September 1995).

2. Shalala D. Secretary of Health and Human Services, Say 'N0' to Legalization of Marijuana, Wall Street Journal (18 August 1995), p. A10.

3. Shuster C. Director of National Institute on Drug Abuse, quoted in Drug Enforcement Administration, Drug Legalization: Myths and Misconceptions, Washington, DC: U.S. Department of Justice (1994), p. 5.

4. Substance Abuse and Mental Health Services Administration, Annual Emergency Room Data 1993, Statistical Series, Series I, Number 13A, Rockville, MD: U.S. Department of Health and Human Services (1996a);

Substance Abuse and Mental Health Services Administration, Preliminary Estimates from the Drug Abuse Warning Network, Advance Report Number 17, Rockville, MD: U.S. Department of Health and Human Services (1996b).

5. Roberts C.D. Data Quality of the Drug Abuse Warning Network, American Journal of Drug and Alcohol Abuse 22: 389401 (1996).

6. Substance Abuse and Mental Health Services Administration, Preliminary Estimates from the 1995 National Household Survey on Drug Abuse, Rockville, MD: U.S. Department of Health and Human Services (1996).

7. Substance Abuse and Mental Health Services Administration (1996a), . 4, p.34.

8. Substance Abuse and Mental Health Services Administration, Annual Medical Examiner Data 1994, Statistical Series, Series I, Number 14B, Rockville, MD: U.S. Department of Health and Human Services (1996).

19. 1. Henneberger M. Pot Surges Back, But It's, Like, a Whole New World, New York Times (6 February 1994), p. E18.

2. Brown L., Director of National Drug Control Policy, quoted in Interview with Lee Brown, Dallas Morning News (21 May 1995).

3. Drug Enforcement Administration, U.S. Drug Threat Assessment, 1993, Washington, DC: U.S. Department of Justice (1993), p. 63.

4. Kleiman M. A.R. Marijuana: Costs of Abuse, Costs of Control, Westport, CT: Greenwood Press (1989), p. 29.

5. Bennett W. Director of National Drug Control Policy, remarks at Conference of Mayors (23 April 1990).

6. Tartaglino A. Subcommittee Hearings to Investigate the Administrations of the Internal Security Act and other Internal Security Laws, Senate Judiciary Committee, Marihuana Hashish Epidemic and its Impact on United States Security, Washington, DC: U.S. Government Printing Office (1974);

DuPont R. interview in Science (1976), p. 647;

Cohen S. Marihuana: A New Ball Game?, Drug Abuse and Alcoholism Newsletter 8, 4 (1979);

Maugh, T.H. Marihuana: New Support for Immune and Reproductive Hazards, Science 190: 86567 (1975).

7. Drug Enforcement Administration, Drug Legalization: Myths and Misconceptions, Washington, DC: U.S.

Department of Justice (1994), p. 4.

8. MacDonald D.I. Drugs, Drinking and Adolescents, Chicago: Year Book Medical Publishers (1984), p. 57.

9. Potency Monitoring Project, Quarterly Reports, University of Mississippi: Research Institute of Pharmaceutical Sciences (1974 to 1996).

10. Perez Reyes M. et al. A Comparison of the Pharmacological Activity of Delta 9 Tetrahydrocannabinol and Its Monohydroxylated Metabolites in Man, Experientia 29: 100910 (1973);

Avico R. et al. Variations of Tetrahydrocannabinol Content in Cannabis Plants to Distinguish the Fibre Type from Drug Type Plants, Bulletin on Narcotics 37: 6165 (1985).

11. Chait L.D. et al. Discriminative Stimulus and Subjective Effects of Smoked Marijuana in Humans, Psychopharmacology 94:20612 (1988);

Jones R.T. Marijuana Induced 'High': Influence of Expectation, Setting and Previous Drug Experience, Pharmacological Reviews 23: 35969 (1971);

Hochman J.S, Brill N.Q. Marijuana Intoxication: Pharmacological and Psychological Effects, Diseases of the Nervous System 32: 67679 (1971).

12. Warner R. Invisible Hand: The Marijuana Business, New York: William Morrow (1986);

Novak W. High Culture: Marijuana in the Lives of Americans, New York: Alfred A. Knopf (1981);

Goldman A. Grass Roots: Marijuana in America Today, New York: Harper & Row (1979).

13. Mikuriya T.H., Aldrich A.R. Cannabis 1988: Old Drug, New Dangers;

The Potency Question, Journal of Psychoactive Drugs 20: 4755 (1988);

Lerner M, Zeffert J.T. Determination of Tetrahydrocannabinol and Related Compounds, Bulletin on Narcotics 20: 5354 (1968);

Ritzlin R.S. et al. Delta 9 Tetrahydrocannabinol Levels in Street Samples of Marijuana and Hashish: Correlation to User Reactions, Clinical Toxicology 15: 45 (1979);

Starks, M. Marijuana Potency, Berkeley: And / Or Press (1977);

Perry D. Street Drug Analysis and Drug Use Trends, Part II, 19691976, PharmChem Newsletter 6, 4 (1977).

14. Summary of Street Drug Results, 1973, PharmChem Newsletter 3, 3 (1974);

Mikuriya T.H., Aldrich A.R. (1988), . 13.

15. Messinger T.A. A Decade of Drug Analysis Results: 19731983, PharmChem Newsletter 13, 2 (1984);

Perry D. (1977), . 13.

16. ElSohly M.A. et al. Constituents of Cannabis Sativa L. XXIV: The Potency of Confiscated Marijuana, Hashish, and Hash Oil Over a Ten Year Period, Journal of Forensic Sciences 29: 50014 (1984).

17. Nahas G.G. Marihuana: Deceptive Weed, New York: Raven Press (1973);

National Commission on Marihuana and Drug Abuse, Marihuana: A Signal of Misunderstanding, Washington, DC: U.S. Government Printing Office (1972);

Sloman L. Reefer Madness: Marijuana in America, New York: Grove Press, Inc. (1979);

Langer J.H. Drugs of Abuse, Drug Enforcement Magazine 2, 2: 27 (1975);

Goldman A. (1979), . 12.

18. Turner C. et al. Constituents of Cannabis Sativa L. IV: Stability of Cannabinoids in Stored Plant Material, Journal of Pharmaceutical Sciences 62: 160105 (1973).

19. Mikuriya T.H., Aldrich A.R. (1988), . 13.

20. Pear R. 155 Indicted as Two Year Federal Drug Inquiry Ends, New York Times (13 March 1981), p. Al2;

Warner R. (1986), . 12;

Kleiman M.A.R. (1980), . 4.

21. Tartaglino A. (1974), . 6.

22. Drug Policy Office, Federal Strategy for Prevention of Drug Abuse and Drug Trafficking, Washington, DC:

The White House (1982).

23. How Much Marijuana do Americans Really Smoke,'' Forensic Drug Abuse Advisor 7, 1:78 (1995).

24. Potency Monitoring Project, Report #46, University of Mississippi: Research Institute of Pharmaceutical Sciences (1993).

25. Department of Health and Human Services, Marijuana and the Cannabinoids, pp. 13144 in Drug Abuse and Drug Abuse Research, Third Triennial Report to Congress from the Secretary (1991).

26. Perez Reyes M. et al. Comparison of Effects of Marijuana Cigarettes of Three Different Potencies, Clinical Pharmacology and Therapeutics 31: 61724 (1982);

Cappell H. et al. Alcohol and Marihuana: A Comparison of Effects on a Temporally Controlled Operant in Humans, Journal of Pharmacology and Experimental Therapeutics 182: 195202 (1972);

Chait L.D. Delta 9 Tetrahy drocannabinol Content and Human Marijuana Self Administration, Psychopharmacology 98: 5155 (1989).

148 : 27. Heishman S.J. et al. Effects of Tettahydrocannabinol Content on Marijuana Smoking Behavior, Subjective Reports, and Performance, Pharmacology Biochemistry and Behavior 34: 17379 (1989);

Perez Reyes M.

Pharmacodynamics of Certain Drugs of Abuse, pp. 287311 in Barnett G, Chiang C.N. (eds) Pharmacokinetics and Pharmacodynamics of Psychoactive Drugs, Foster City, CA: Biomedical Publications (1985);

Perez Reyes M.

Marijuana Smoking: Factors that Influence the Bioavailablity of Tetrahydrocannabinol, pp. 4262 in Chiang N.C., Hawks R.L. (eds) Research Findings on Smoking of Abused Substances, Rockville, MD: National Institute on Drug Abuse (1990).

28. Chait L.D, Zacny J.R. Reinforcing and Subjective Effects of Oral Delta 9 THC and Smoked Marijuana in Humans, Psychopharmacology 107: 25562 (1992);

Kelly T.H. et al. Effects of Delta 9 THC on Marijuana Smoking, Dose Choice, and Verbal Report of Drug Liking, Journal of Experimental Analysis of Behavior 61: 203 11 (1994);

Wu H. et al, Effects of Smoked Marijuana of Varying Potency on Ventilatory Drive and Metabolic Rate, American Review of Respiratory Disease 146: 71621 (1992);

Chait L.D. et al. A Cumulative Dosing Procedure for Administering Marijuana Smoke to Humans, Pharmacology Biochemistry and Behavior 29: 55357 (1988);

Higgins S.T., Stitzer M.L. Acute Marijuana Effects on Social Conversation, Psychopharmacology 89: 234 (1986);

Cappell, H. et al. (1972), . 26;

Heishman S.I. et al. (1989), . 27.

29. Herning R.I. et al. Tetrahydrocannabinol Content and Differences in Marijuana Smoking Behavior, Psychopharmacology 90: 16062 (1986).

30. Chait L.D. (1989), . 26.

31. Oviedo A. et al. Chronic Cannabinoid Administration Alters Cannabinoid Receptor Binding in Rat Brain:

A Quantitative Autoradiographic Study, Brain Research 616: 293302 (1993).

32. Ritzlin R.S. et al. (1979), . 13.

33. Calahan D, Room R. Problem Drinking Among American Men, New Brunswick, NJ: Rutgers Center of Alcohol Studies (1974);

Swift G.C., Tiplady D. The Effects of Age on the Response to Caffeine, Psychopharmacology 94: 2931 (1988).

34. Johnston L.D. et al. National Survey Results on Drug Use from the Monitoring the Future Study, 1975 1995, Volume I: Secondary School Students, Rockville, MD: US. Department of Health and Human Services (1996), p. 198.

35. Rosenthal E. Marijuana Growing Tips, Berkeley, CA: And / Or Books (1986);

Prank, M. Marijuana Growers' Insiders Guide, Los Angeles: Red Eye Press (1988).

20. 1. Center on Addiction and Substance Abuse, National Survey of American Attitudes on Substance Abuse, New York (1995), p. 28.

2. Brown L., Director of National Drug Control Policy, remarks at National Conference on Marijuana Use:

Prevention, Treatment, and Research, sponsored by the National Institute on Drug Abuse, Arlington, VA (July 1995).

3. Califano J.A. Don't Stop This War, Washington Post (26 May 1996), p. C7.

4. Shalala D., quoted in Marijuana: A Recurring Problem, Prevention Pipeline 8, 5 (1995), p. 2.

5. Burke J. Partnership for a Drug Free America, remarks on MS NBC with Tom Brokaw (3 September 1996).

6. Falco M. The Making of a Drug Free America: Programs That Work, New York: Times Books (1992), p. 202.

7. Drug Policy Office, Federal Strategy for Prevention of Drug Abuse and Drug Trafficking, Washington, DC:

The White House (1982).

8. Baum D. Smoke and Mirrors: The War on Drugs and the Politics of Failure, Boston: Little, Brown and Company (1996).

9. National Institute on Justice, The DARE Program: A Review of Prevalence, User Satisfaction, and Effectiveness, National Institute of Justice Update, Washington, DC: U.S. Department of Justice (1994);

Bureau of Justice Statistics, An Introduction to DARE: Drug Abuse Resistance Education, second edition, Washington, DC:

U.S. Department of Justice (1992).

10. U.S. Department of Education and U.S. Department of Health and Human Services, Report to Congress and the White House on the Nature and Effectiveness of Federal, State, and Local Drug Prevention / Education Programs, Washington, DC: U.S. Government Printing Office (1987);

U.S. Department of Education, Drug Prevention Curricula: A Guide to Selection and Implementation, Washington, DC: U.S. Government Printing Office (1988).

11. Interview with Thomas A. Hedrick, Partnership for a Drug Free America, The Facts About Tobacco, Alcohol and Other Drugs 4, 2: 1 (1995).

12. Center for Substance Abuse Prevention, Young Teens: Who They Are and How to Communicate with Them About Alcohol and Other Drugs, Rockville, MD: U.S. Department of Health and Human Services (1991).

13. University of Michigan Press Release, The Rise in Drug Use Among American Teens Continues in 1996, Ann Arbor: News and Information Services (19 December 1996).

14. University of Michigan (1996), . 13.

15. Johnston L.D. et al. National Survey Results on Drug Use from the Monitoring the Future Study, 1975 1995, Volume I: Secondary School Students, Rockville, MD: U.S. Department of Health and Human Services (1996).

16. Shedler J., Block J. Adolescent Drug Use and Psychological Health, American Psychologist 45: 612 30 (1990).

17. Johnston L.D. et al. (1996), . 15.

18. Block J. et al. Longitudinally Foretelling Drug Usage in Adolescence: Early Childhood Personality and Environmental Precursors, Child Development 59: 33655 (1988);

Robins L.N., McEvoy L. Conduct Problems as Predictors of Substance Abuse, pp. 182204 in Robins L.N., Rutter M. (eds) Straight and Devious Pathways From Childhood to Adulthood, Cambridge: Cambridge University Press (1990);

Donovan J.E. et al. Syndrome of Problem Behavior in Adolescence: A Replication, Journal of Consulting and Clinical Psychology 56: 76265 (1988);

Scheier L.M., Newcombe M.D. Psychosocial Predictors of Drug Use Initiation and Escalation: An Expansion of the Multiple Risk Factors Hypothesis Using Longitudinal Data, Contemporary Drug Problems 18: 3173 (1991);

Farrell A.D. et al. Relationship Between Drug Use and Other Problem Behaviors in Urban Adolescents, Journal of Consulting and Clinical Psychology 60: 70512 (1992);

Kandel D.P., Davies M. High School Students Who Use Crack and Other Drugs, Archives of General Psychiatry 53: 7180 (1996);

Shedler I., Block I. (1990), . 16.

19. Shalala D. Reality Check: Q & A, Rockville, MD: Center for Substance Abuse Prevention (1996).

20. Remarks at National Conference on Marijuana Use (July 1995), . 2.

21. Alan Leschner, quoted in Swan N. Marijuana, Other Drug Use Among Teens Continues to Rise, NIDA Notes 10, 2 (1995), p. 2.

22. Senate Judiciary Committee Hearings, Teenage Drug Use (4 September 1996).

23.. Quoted in Suro R. U.S., Private Sector Would Split $3 Million Cost, Washington Post (13 February 1997), p. Al.

24 Flay B.R., Sobel J.L. The Role of Mass Media in Preventing Adolescent Substance Abuse, pp. 535 in Glynn T.J. et al. (eds) Preventing Adolescent Drug Abuse: Intervention Strategies, Rockville, MD: National Institute on Drug Abuse (1983).

25. Black G.S. Changing Attitudes Toward Drug Use, Rochester, NY: Gordon S. Black Corporation (1988).

26. National Institute on Drug Abuse, National Ad Campaign 'Unsells' Drugs, NIDA Notes 3, 2: 4 (1988);

Partnership for a Drug Free America, 1995 Partnership Attitude Tracking Survey, New York (1996).

27. Brecher E.M. Licit and Illicit Drugs, Boston: Little, Brown and Company (1972).

28. Bass L. Public Perceptions of Marijuana: Knowledge, Attitudes, and Norms, paper presented at National Conference on Marijuana Use: Prevention, Treatment, and Research, sponsored by the National Institute on Drug Abuse, Arlington, VA (July 1995);

Brown L. remarks at National Conference on Marijuana Use (July 1995);

Burke J.E.

Partnership for a Drug Free America Press Release (12 December 1994);

Drug Enforcement Administration, Marijuana Blunts, Washington, DC: U.S. Department of Justice (1994);

Califano J.A. Forward, pp. 24 in Center on Addiction and Substance Abuse, National Survey of American Attitudes on Substance Abuse, New York (1995);

Guttman, M. The New Pot Culture, USA Weekend (16 February 1996), pp. 47.

29. Bonnie R.J., Whitebread C.N. The Marihuana Conviction: A History of Marihuana Prohibition in the United States, Charlottesville: University of Virginia Press (1974);

National Commission on Marihuana and Drug Abuse, Marihuana: A Signal of Misunderstanding, Washington, DC: U.S. Government Printing Office (1972).

30. Braucht G.N. et al. Drug Education: A Review of Goals, Approaches and Effectiveness, and a Paradigm for Evaluation, Quarterly Journal of Studies of Alcohol 34: 127992 (1973);

Boldt R.F. et al. A Survey and Assessment of the Current Status of Drug Related Instructional Programs in Secondary and Elementary Institutions, pp. 455547 in National Commission on Marihuana and Drug Abuse, Drug Use in America: Problem in Perspective, 150 : Vol. 2, Washington, DC: U.S. Government Printing Office (1973);

Swisher J., Hoffman A. Information: The Irrelevent Variable in Drug Education, pp. 4962 in Corder B. et al. (eds) Drug Abuse Prevention, Dubuque, I.A:

W.C. Brown Company (1975);

Blum R. et al. Drug Education: Results and Recommendations, Lexington, MA:

Lexington Books (1976);

Berberian R.M. et al. The Effectiveness of Drug Education Programs: A Critical Review, Health Education Monographs 4: 37798 (1976);

Goodstadt M.S. Drug Education A Turn On Or a Turn Off?, Journal of Drug Education 10: 8999 (1980);

Schaps E. et al. A Review of 127 Drug Abuse Prevention Programs, Journal of Drug Issues 11: 1734 (1981);

Moskowitz J.M. Evaluation of a Substance Abuse Prevention Program for Junior High School Students, International Journal of the Addictions 19: 41930 (1984);

Bangert Drowns R.L. The Effects of School Based Substance Abuse Education A Meta Analysis, Journal of Drug Education 18:

24364 (1988);

Tobler N.S. Meta Analysis of 143 Adolescent Drug Prevention Programs: Quantitative Outcome Results of Program Participants Compared to a Control or Comparison Group, Journal of Drug issues 16: 537 (1986).

31. DeJong W. Arresting the Demand For Drugs: Police and School Partnerships to Prevent Drug Abuse, Washington, DC: National Institute of Justice (1987);

Botvin G.J. Principles of Prevention, pp. 1944 in Coombs R.H., Ziedonis D.M. (eds) Handbook on Drug Abuse Prevention: A Comprehensive Strategy to Prevent the Abuse of Alcohol and Other Drugs, Boston: Allyn and Bacon (1995);

Ellickson P.L. Schools, pp. 93120 in Coombs R.H., Ziedonis D.M. (eds) Handbook on Drug Abuse Prevention: A Comprehensive Strategy to Prevent the Abuse of Alcohol and Other Drugs, Boston: Allyn and Bacon (1995);

Falco M. (1992), . 6.

32. U.S. Department of Education (1988), . 10.

33. Pentz M.A. et al. A Multicommunity Trial for Primary Prevention of Adolescent Drug Abuse: Effects on Drug Use Prevalence, Journal of the American Medical Association 261: 325966 (1989);

Johnson C.A. et al.

Relative Effectiveness of Comprehensive Community Programming for Drug Abuse Prevention With High Risk and Low Risk Adolescents, Journal of Consulting and Clinical Psychology 58: 44756 (1990).

34. Flay B.R. et al. Effects of Program Implementation on Adolescent Drug Use Behavior, Evaluation Review 14:

41649 (1990);

Ellickson P.L., Bell R.M. Drug Prevention in Junior High: A Multi Cite Longitudinal Test, Science 247:

12991305 (1990);

Ellickson P.L. et al. Preventing Adolescent Drug Use: Long Term Results of a Junior High Program, American Journal of Public Health 83: 85661 (1993);

Botvin G.J. et al. Long Term Follow Up of a Randomized Drug Abuse Prevention Trial in a White Middle Class Population, Journal of the American Medical Association 273:1106 (1995);

Hansen W.B. et al. Affective and Social Influences Approaches to the Prevention of Multiple Substance Abuse among Seventh Grade Students: Results from Project SMART, Preventative Medicine 17: 13554 (1988).

35. Wysong E. et al. Truth and Dare: Tracking Drug Education to Graduation and as Symbolic Politics, Social Problems 41: 44872 (1994);

Ennett S.T. et al. How Effective Is Drug Abuse Resistance Training? A Meta Analysis of Project DARE Outcome Evaluations, American Journal of Public Health 84: 13941401 (1994);

Rosenbaum D.P. et al. Cops in the Classroom: A Longitudinal Evaluation of Drug Abuse Resistance Education (DARE), Journal of Research in Crime and Delinquency 31: 331 (1994);

Dukes R.L. et al. Three Year Follow Up of Drug Abuse Resistance Training (D.A.R.E.), Evaluation Review 20: 4966 (1996) 36. Brown J.H. et al. Students and Substances: Social Power in Drug Education, Educational Evaluation and Policy Analysis 19: 6582 (1997).

37. Johnston L.D. et al. (1996), . 15.

38. National Commission on Drug Free Schools, Toward a Drug Free Generation: A Nation's Responsibility, Washington, DC: U.S. Department of Education (1990).

39. Brown I.H. et al. (1997), . 36.

40. U.S. Department of Education (1988), . 10, p. 13.

41. United States General Accounting Office, Drug Abuse Prevention: Federal Efforts to Identify Exemplary Programs Need Stronger Design, Washington, DC: United States General Accounting Office (1991).

42. Saunders B. Illicit Drugs and Harm Reduction Education, Addiction Research 2: i iii (1995);

Goodstadt M.S. Drug Education, Washington, DC: U.S. Department of Justice (1988);

Moskowitz J.M. The Primary Prevention of Alcohol Problems: A Critical Review of the Research Literature, Journal of Studies on Alcohol 50: 5488 (1989);

Polich J.M. et al. Strategies for Controlling Adolescent Drug Use, Santa Monica, CA: Rand Corporation (1984);

Cohen J. Drug Education, Politics, Propaganda and Censorship, International Journal of Drug Policy 1: 153 (1996);

Rosenbaum M. Kids, Drugs, and Drug Education: A Harm Reduction Approach, San Francisco: National Council on Crime and Delinquency (1996);

Engs R.C., Fors S.W. Drug Abuse Hysteria: The Challenge of Keeping Perspective, Journal of School Health 58: 2628 (1988);

Duncan D.F. Drug Abuse Prevention in Post Legalization America: What Could It Be Like?, Journal of Primary Prevention 12: 31722 (1992);

Brown J.H. Drug Education and Democracy in Action, Multidisciplinary Association for Psychedelic Studies 7, 1: 2834 (1997);

Nadelmann E.A. Stop Kidding About Drug Free Kids, Los Angeles Times (3 January 1997).

43. National Institute on Drug Abuse, Doing Drug Education: The Role of the School Teacher, Rockville, MD (1975).

44. National Institute on Drug Abuse, Let's Talk About Drug Abuse: Some Questions and Answers, Rockville, MD: U.S. Department of Health, Education, and Welfare (1979);

National Institute on Drug Abuse, This Side Up:

Making Decisions About Drugs, Rockville, MD: U.S. Department of Health, Education, and Welfare (1977).

45. Swisher J.D. Prevention Issues, pp. 42335 in DuPont, R.L. et al. (eds) Handbook on Drug Abuse, Rockville, MD: National Institute on Drug Abuse (1979);

Abrams A. et al. (eds) Accountability in Drug Education:

A Model for Evaluation, Washington, DC: Drug Abuse Council (1973);

Bushy J. Drug Education: Goals, Approaches, Evaluation, Arlington, VA: Educational Research Service (1975);

Girdana D., Girdana D. Drug Education: Content and Methods, Reading, MA: Addison Wesley (1972);

Edwards G. Reaching Out, New York: Holt, Rhinehard and Winston (1971);

Cornacchio H. Drugs in the Classroom: A Conceptual Model for School Programs, St. Louis: C.V.

Mosby (1973);

Dohner V.A. Alternatives to Drugs, Journal of Drug Education 2: 322 (1972).

46. Drug Policy Office, Federal Strategy for Prevention of Drug Abuse and Drug Trafficking, Washington, DC:

The White House (1982).

47. U.S. Department of Education, What Works: Schools Without Drugs, Washington, DC (1986).

48. Lindblad R.A. A Review of the Concerned Parent Movement in the United States of America, Bulletin on Narcotics 35, 3: 4152 (1983);

Booth W. War Breaks Out Over an Agency, Science 211: 64850 (1988);

Jaffe J.H. Footnotes in the Evolution of the American National Response: Some Little Known Aspects of the First American Strategy for Drug Abuse and Drug Trafficking Prevention, British Journal of Addiction 82: 587 (1987).

49. Cohen J. Achieving a Reduction in Drug Related Harm Through Education, pp. 6576 in Heather N. et al. Psychoactive Drugs an dHarm Reduction: From Faith to Science, London: Whurr (1993);

Staples P. Reduction of Alcohol and Drug Related Harm in Australia: A Government Minister's Perspective, pp. 4954 in Heather N. et al. Psychoactive Drugs and Harm Reduction: From Faith to Science, London: Whurr (1993);

Marshall I.H., Marshall C.E. Drug Prevention in the Netherlands A Low Key Approach, pp. 20532 in Leuw E, Marshall I.H. (eds) Between Prohibition and Legalization: The Dutch Experiment in Drug Policy, Amsterdam: Kugler Publications (1994).

50. Lifeline, 101 103 Oldham Street, Manchester, England M4 1 LW.

51. McDermott P. et al. Ecstasy in the United Kingdom: Recreational Drug Use and Subcultural Change, pp.

23044 in Heather N. et al. (eds) Psychoactive Drugs and Harm Reduction: From Faith to Science, London: Whurr (1993);

Fromberg E. A Harm Reduction Educational Strategy Toward Ecstasy, pp. 146153 in O'Hare P.A. et al. (eds) The Reduction of Drug Related Harm, New York: Routledge (1992).

52. Netherlands Institute on Alcohol and Drugs, Cannabis Policy Fact Sheet, Netherlands Alcohol and Drug Report 1 (1995).

53. Jacobs J.B. Drunk Driving: An American Dilemma, Chicago: University of Chicago Press (1989).

54. Cohen J., Kay J. Taking Drugs Seriously: A Parent's Guide to Young People's Drug Use, Great Britain:

Thorsons (1994);

Miller M., Burbank S. Teach Your Children Well: A Rational Guide to Family Drug Education, Mosier, OR: Mothers Against Misuse and Abuse (1995);

De Miranda J. Do Our Drug Prevention Messages Underestimate Kids?, Alcoholism and Drug Abuse Weekly (17 February 1997);

Anonymous, The Rite of Passage:

A Family's Perspective on the Use of MDMA, Multidisciplinary Association for Psychedelic Studies 7, 1: 40 (1997);

Anonymous, Stumbling on His Stash, Multidisciplinary Association for Psychedelic Studies 7, 1: 37 (1997);

Beam A. Getting Real About Drugs, Boston Globe (25 November 1991).

55. Center on Addiction and Substance Abuse, National Survey of American Attitudes on Substance Abuse, New York (1995);

Center on Addiction and Substance Abuse, National Survey of American Attitudes on Substance Abuse II: Teens and Their Parents, New York (1996).

1. Advisory Committee on Drug Dependence, Cannabis, London: Her Majesty's Stationery Office (1969).

2. Canadian Government Commission of Inquiry, The Non Medical Use of Drugs, Ottawa, Canada: Information Canada (1970).

3. National Commission on Marihuana and Drug Abuse, Marihuana: A Signal of Misunderstanding, Washington, DC: U.S. Government Printing Office (1972).

152 : 4. Werkgroep Verdovende Middelen, Background and Risks of Drug Use, The Hague: Staatsuigeverij (1972).

5. Senate Standing Committee on Social Welfare, Drug Problems in Australia An Intoxicated Society, Canberra:

Australian Government Publishing Service (1977).

6. National Research Council, An Analysis of Marijuana Policy, Washington, DC: National Academy Press (1982).

7. McDonald D. et al. Legislative Options for Cannabis in Australia, Report on the National Task Force on Cannabis, Canberra: Australian Government Publishing Service (1994).

8. Ministry of Health, Welfare and Sport, Drugs Policy in the Netherlands: Continuity and Change, The Netherlands (1995).

9. National Commission on Marihuana and Drug Abuse, Marihuana Use in American Society, pp. 249 in Marihuana: A Signal of Misunderstanding, Appendix I, Washington, DC: U.S. Government Printing Office (1972).

10. National Commission on Marihuana and Drug Abuse, Enforcement Behavior at the State Level, pp. 612 728 in Marihuana: A Signal of Misunderstanding, Apendix 11, Washington, DC: U.S. Government Printing Office (1972).

11. National Commission on Marihuana and Drug Abuse, A Nationwide Study of Beliefs, Information and Experiences, pp. 855968 in Marihuana: A Signal of Misunderstanding, Apendix 11, Washington, DC;

U.S.

Government Printing Office (1972).

12. National Commission on Marihuana and Drug Abuse, Opinion Within the Criminal Justice System, pp.

782852 in Marihuana: A Signal of Misunderstanding, Apendix 11, Washington, DC: U.S. Government Printing Office (1972) 13. Subcommittee Hearings to Investigate Juvenile Delinquency, Senate Judiciary Committee, Marijuana Decriminalization, Washington, DC: U.S. Government Printing Office (1975).

14. New York Academy of Medicine, Committee on Public Health, Marihuana and Drug Abuse, Bulletin of the New York Academy of Medicine 49: 7780 (1973).

15. Quoted in Baum D. Smoke and Mirrors: The War on Drugs and the Politics of Failure, Boston: Little, Brown and Company (1996), p. 92.

16. Subcommittee Hearings to Investigate Juvenile Delinquency, Senate Judiciary Committee (1975), . 13, p. 6.

17. Quoted in DiChiara A., Galliher J.I. Dissonance and Contradictions in the Origins of Marihuana Decriminalization, Law and Society Review 28: 4177 (1994), p. 58.

18. Quoted in Marihuana and Health in Perspective, Summary and Comments and Fischer, B. Canadian Cannabis Policy: The Impact of Criminalization, the Current Reality and Future Policy Options, pp. 22742 in Bollinger L. (ed) Cannabis Science: From Prohibition to Human Right, New York: Peter Lang (1997).

19. DiChiara A., Galliher I.I. (1994), . 17, p. 55.

20. DiChiara A., Galliher I.I. (1994), . 17, p. 53.

21. DiChiara A., Galliher I.I. (1994), . 17, p. 52.

22. DiChiara A., Galliher I.I. (1994), . 17, p. 51.

23. President's Advisory Commission on Narcotics and Drug Abuse, Final Report, Washington, DC: U.S.

Government Printing Office (1963).

24. President's Commission on Law Enforcement and the Administration of Justice, Task Force Report on Narcotics and Drug Abuse, Washington, DC: U.S. Government Printing Office (1967).

25. National Institute of Law Enforcement and Criminal Justice, Marijuana: A Study of State Policies and Penalties, Washington, DC: U.S. Department of Justice (1977).

26. DiChiara A., Galliher I.I. (1994), . 17.

27. Subcommittee Hearings to Investigate the Administration of the Internal Security Act and Other Internal Security Laws, Marihuana Hashish Epidemic and Its Impact on United States Security, Washington, DC: U.S.

Government Printing Office (1974).

28. Slaughter J.B. Marijuana Prohibition in the United States: History and Analysis of a Failed Policy, Columbia Journal of Law and Social Problems 21: 41774(1988).

29. Johnston L.D. et al. National Survey Results on Drug Use from the Monitoring the Future Study, 1975 1995, Vol. I, Secondary School Students, Rockville, MD: U.S. Department of Health and Human Services (1996).

30. Cook M.H., Newman C. This Side Up, Rockville, MD: National Institute on Drug Abuse (1977);

Drug Abuse Prevention for Your Family, Rockville, MD: National Institute on Drug Abuse (1977).

31. Manatt M. Parents, Peers and Pot, Rockville, MD: National Institute on Drug Abuse (1979);

Manatt M.

Parents, Peers and Pot II, Rockville, MD: National Institute on Drug Abuse (1983);

Mann P. Marijuana Alert, New York: McGraw Hill Book Company (1985);

National Institute on Drug Abuse, Celebrating Parent Power in Georgia, Prevention Resources 3, 34 (1978).

32. National Institute on Drug Abuse, Prevention at the Grassroots, Prevention Resources 6, 1 (1982).

33. National Institute on Drug Abuse, State of the Art Report on the Parent Movement Rockville,MD (1981).

34. Lindblad R.A. A Review of the Concerned Parent Movement in the United States of America, Bulletin on Narcotics 35, 3: 4152 (1983);

Jaffe J.H. Footnotes in the Evolution of the American National Response: Some Little Known Aspects of the First American Strategy for Drug Abuse and Drug Trafficking Prevention, British Journal of Addiction 82: 587600 (1987).

35. DuPont R.L. Getting Tough on Gateway Drugs, Washington, DC: American Psychiatric Press (1984).

36. Manatt M. (1979), . 32.

37. Baum D. (1996), . 15.

38. Mann P. Marijuana Update, Pleasantvillle, NY: Reader's Digest (1982), pp. 3, 11, 17.

39. Mann P. (1985), . 32.

40. The American Council on Marijuana was later renamed the American Council on Marijuana and Other Psychoactive Drugs, and then the American Council for Drug Education.

41. For example, Heath R.G. Marijuana and the Brain, Rockville, MD: American Council on Marijuana and Other Psychoactive Drugs (1981);

Tashkin D.P., Cohen S. Marijuana Smoking and Its Effects on the Lungs, Rockville, MD: American Council on Marijuana and Other Psychoactive Drugs (1981);

Turner C.E. The Marijuana Controversy, Rockville, MD: American Council on Marijuana and Other Psychoactive Drugs (1981);

Moskowitz H., Petersen R.

Marijuana and Driving, Rockville, MD: American Council on Marijuana and Other Psychoactive Drugs (1982);

Smith C.G., Asch R.H. Marijuana and Reproduction, Rockville, MD: American Council on Marijuana and Other Psychoactive Drugs (1982).

42. Russell G.K. Marihuana Today: A Compilation of Medical Findings for the Layman, New York: The Myrin Institute (1978).

43. Nahas G.G. Marihuana Deceptive Weed, New York: Raven Press (1973);

Nahas G.G. Keep Off the Grass, New York: Reader's Digest Press (1976).

44. Nahas G.G. (1976), . 44, pp. 152, 163.

45. Reagan Warns Against Easier 'Pot' Penalties, Los Angeles Times (5 December 1974), p. 32.

46. Drug Policy Office, Federal Strategy for Prevention of Drug Abuse and Drug Trafficking, Washington, DC:

The White House (1982).

47. Discussion Highlights, pp. 100108 in National Institute on Drug Abuse, Marijuana and Youth: Clinical Observations on Motivation and Learning, Rockville, MD (1982), p. 101.

48. Highlights of Final Discussion, pp. 109120 in National Institute on Drug Abuse, Marijuana and Youth:

Clinical Observations on Motivation and Learning, Rockville, MD (1982), pp. 11415.

49. National Institute on Drug Abuse, Marijuana and Health, Ninth Report to the U.S. Congress from the Secretary of Health and Human Services (1982).

50. National Institute on Drug Abuse, Marijuana and Health, Eighth Annual Report to the U.S. Congress from the Secretary of Health, Education, and Welfare (1980).

51. Kleiman M.A.R. Marijuana: Costs of Abuse, Costs of Control, New York: Greenwood Press (1989);

Reuter P.

On the Consequences of Toughness, pp. 138164 in Kraus M.B., Lazear E.P. Searching for Alternatives: Drug Control Policy in the United States, Stanford: Hoover Institution Press (1991);

Baum D. (1996), . 15.

52. Gordon D.R. The Return of the Dangerous Classes: Drug Prohibition and Policy Politics, New York: W.W.

Norton & Company (1994);

Trebach A.S. The Great Drug War, New York: Macmillan Publishing Company (1987).

53. Federal Bureau of Investigation, Uniform Crime Reports, Washington, DC: U.S. Department of Justice (19911995).

54. Marijuana Policy Project, Smoke a Joint, Lose Your License: July 1995 Status Report, Washington, DC (1995).

154 : 55. Marijuana Policy Project, MPP Analyzes States' Medicinal Marijuana Laws, Marijuana Policy Report 2, 3:

16 (1996);

Wren C.S. Votes on Marijuana are Stirring Debate, New York Times (17 November 1996), p. 16.

56. Drug Enforcement Administration, Drug Legalization: Myths and Misconceptions, Washington, DC: U.S.

Department of Justice (1994);

McCaffrey B., Director of National Drug Control Policy, Senate Judiciary Committee Hearings, Teenage Drug Use (4 September 1996);

Office of National Drug Control Policy, The Administration's Response to the Passage of California Proposition 215 and Arizona Proposition 200, Washington, DC: The White House (30 December 1996);

Doctors Given Federal Threat on Marijuana: U.S. Acts to Overcome States' Easing of Law, New York Times (31 December 1996), p. 1.

57. Office of National Drug Control Policy, National Drug Control Strategy, Washington, DC (1989), p. 47.

58. U.S. Department of Education, What Works: Schools Without Drugs, Washington, DC (1992);

Office of National Drug Control Policy (1989), . 58.

59. American Management Association, 1994 Survey on Workplace Drug Testing and Drug Abuse Policies, New York (1994).

60. Booth W. Florida County Sets Drug Tests for Welfare Clients, Washington Post (17 September 1996), p. A3.

61. Boodman S.G. Testing Your Children for Drugs, Washington Post Health (25 February 1997), p. 12.

62. Glass S. Don't You D.A.R.E. New Republic (3 March 1997), pp. 1828.

63. Substance Abuse and Mental Health Services Administration, National Household Survey on Drug Abuse:

Main Findings 1994, Rockville, MD: U.S. Department of Health and Human Services (1996);

Johnson L.D. et al.

(1996), . 30.

64. For example, Center on Addiction and Substance Abuse, Cigarettes, Alcohol, Marijuana: Gateways to Illicit Drug Use, New York (1994);

Center on Addiction and Substance Abuse, National Survey of American Attitudes on Substance Abuse, New York (1995);

Center on Addiction and Substance Abuse, National Survey of American Attitudes on Substance Abuse II: Teens and Their Parents, New York (1996).

65. Leshner A.I. Marijuana Initiative Features Scientifically Accurate Messages, NIDA Notes 10, 4: 3 (1995).

66. Partnership for a Drug Free America Press Release, With Potential Marijuana Crisis Re Emerging, Partnership Launches Massive Advertising Blitz on Marijuana, New York (23 January 1995).

67. Hadi N. The Reality Check Campaign, Prevention Pipeline 9, 4: 56 (1996).

68. Quoted in NIDA Conference Advances HHS Secretary's Marijuana Initiative, NIDA Notes 10, 6: 5 (1995).

69. Ministry of Health, Welfare and Sport (1995), . 8.

70. Bollinger L. German Drug Law in Action, pp. 15368 in Bollinger L. (ed) Cannabis Science: From Prohibition to Human Right, Frankfurt: Peter Lang (1997);

Arnao G. Anti Prohibitionism: Prospects For the Future, pp. 107203 in Questioning Prohibition: 1994 International Report on Drugs, Brussels: International Antiprohibitionist League (1994);

Radical Anti Prohibitionist Cordination, The Cora and the Italian Referendum on Drugs, pp. 15152 in Questioning Prohibition: 1994 International Report on Drugs, Brussels: International Antiprohibitionist League (1994);

McDonald D. et al. (1994), . 7.

71. McDonald D. et al. (1994), . 7.

72. Bonnie R.J. America's Drug Policy: Time for Another Commission?, Contemporary Drug Problems 20:

395408 (1993).

73. National Commission on Drug Free Schools, Towards a Drug Free Generation: A Nation's Responsibility, Washington, DC: U.S. Department of Education (1990);

Office of National Drug Control Policy, National Drug Control Strategy, Washington, DC: The White House (1995);

U.S. Department of Health and Human Services Press Release, Marijuana and Tobacco Use Still Rising Among 8th and 10th Graders, Rockville, MD (19 December 1996).

74. Center on Addiction and Substance Abuse, Legalization: Panacea or Pandora's Box, New York (1995);

Gorman T.J. The Myths of Drug Legalization, Santa Clarita, CA: California Narcotics Officers' Association (1994);

Drug Enforcement Administration (1994), . 57.

75. Adlaf E. et al. The Ontario Student Drug Use Survey: 19751995, Toronto: Addiction Research Foundation (1995);

Donnelly N., Hall W. Patterns of Cannabis Use in Australia, Canberra: Australian Government Publishing Service (1994);

Harrison L.D. More Cannabis in Europe? Perspectives from the USA, paper presented at the Conference on Drug Use and Drug Policy, European Research Group on Drug Issues and Drug Policy, Amsterdam (September 1996).

76. Single E. The Impact of Marijuana Decriminalization: An Update, Journal of Public Health Policy 10:

45666 (1989);

Johnston L.D. et al. Marijuana Decriminalization: The Impact on Youth, 19751980, Monitoring the Future, Occasional Paper 13, Ann Arbor: University of Michigan (1981);

Saveland W., Bray D.F. Trends in Cannabis Use Among American States with Different and Changing Legal Regimes, 19721977, Contemporary Drug Problems 10: 33561 (1981).

77. Belden, Russonello American Voters' Opinions on the Use and Legalization of Marijuana, national random poll conducted for the American Civil Liberties Union, New York (1995).

78. Bureau of Justice Statistics, Sourcebook of Criminal Justice Statistics 1994, Washington, DC: U.S.

Department of Justice (1994), p. 197;

Partnership for a Drug Free America, 1995 Partnership Attitude Tacking Study, New York (1996);

Center on Addiction and Substance Abuse (1995), . 65;

Center on Addiction and Substance Abuse (1996), . 65;

Belden, Russonello (1995), . 78.

79. Johnston L.D. et al. (1996), . 30.

80. Bureau of Justice Statistics, Sourcebook of Criminal Justice Statistics 1995, Washington, DC: U.S.

Department of Justice (1995), p. 219.

81. The Field Institute, poll of California voters' support for Proposition 215 (1996);

Center on Addiction and Substance Abuse Press Release, Majority of Californians Support Marijuana for Terminally Ill But Reject Other Provisions (28 October 1996);

Lake Research, Inc. national random poll conducted for the Lindesmith Center, New York (1997);

Belden, Russonello (1995), . 78.

82. Center on Substance Abuse Prevention, Marijuana Issues: Meeting Summary, Rockville, MD: U.S.

Department of Health and Human Services (April 1995);

Center on Addiction and Substance Abuse (1995), . 65;

Center on Addiction and Substance Abuse (1996), . 65;

Partnership for a Drug Free America (1996), . 79.

83. Substance Abuse and Mental Health Services Administration (1996), . 64.

156 : 88, 89 17, 40, 41, 103 30, 92, 35 28, 43, 58, 64, 65 52, 67, 94, 95, 96, 31, 32, 33, 77, 88, 89, 90, 91, 93, 21, Journal of the American Medical Association 24, 24, 27, 18, 26, 35, 76, 76, 80, 17, 18, 66, 15, 18, 33, 47, 57, 64, 76, 80, 21, 16, 35, 25, 40, 43, 54, 55, 59, 62, 78, 96, 62 25 47, 57, 73 30, 31, 32, 33, 42, 43, 78, 92, 93 107 LaGuardia 12 , Shafer 15, 16, 17, 19, 35 28, 31, 77, 97 28, 78, 80, 81, 30, 31, 17, 20, 43, 47, 52, 53, 54, 55, 20, 21, 22, 23, 24, , 14, 15, 16, 19, 20, 21, 23, 24, 47, 99, 25, 26, 28, 30, 31, 33, 34, 41, 42, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 56, 58, 57, 89, 59, 60, 61, 62, 63, 64, 65, 66, 68, 69, 70, 71, 72, 74, 75, 76, 77, 78, 80, 82, 88, 89, 32, 33, 57, 60, 61, 93, 99, 90, 91, 92, 93, 94, 95, 96, 97, 100, 100, 16, 66, 19, 28, 31, 17, 33, 34, 93, 94, 99, 32, 33, 41, 45, 48, 49, 50, 51, 53, 54, 55, 56, 57, 58, 60, 61, 62, 64, 65, 76, 77, 80, 82, 91, 92, 96, 27, 48, 47, 58, 52, 58, 61, 158 : 17, 66, 67, 28, 68, 49, 50, 19, 49, 50, 51, 70, 73, 80, 55, 56, . 23, 99, 88, 89, 26, 27, Eastland 58, 90, 20, 21, 22, 24, 25, 76, 78, 17, 54, 31, 33, 55, 74, 75, 78, 80, 81, 82, 17, 18, 20, 21, 22, 23, 27, 28, 33, 44, 51, 52, 53, 57, 65, 73, 77, 81, 83, 84, 85, 86, 88, 91, 93, 94, 95, 97, 99, 100, 101, 102, 31, Mann P. Anslinger . McCaffrey B. Bennett W. Macdonald D.I. Benowitz N. Miller N. Block R. and Ghoneim M. 55, Nahas G. 16, Bonnie R.J. Pertwee R. Eastland J. Pope H. and Yurgelun Todd D. Elders J. Schwartz R. Foltin R. Shafer R. Fried R. 73, Shalala D. Gingrich N. Soueif M.I. Gold M. Tashkin D. Henningfield J. THC 22, 23, 25, 61, 65, IQ 55, 56, Weil A. Kandel D. Young F. Kolodny R. Lawn J. 23, ............................................................................... .................................................................... ................................................................................................................. ........................................................................................................................ 1. .............................................................................................. 2. ................................................................................. 3. ................................................................................... 4. , .................... 5. , ...................................................................................................... 6. ........................................... 7. .............................................................................. 8. , .............................................. 9. , .................................. 10. , ......................................... 11. , .................................. 12. , ...................... 13. .................................. 14. ....................................................................... 15. ........................................................................... 16. ...................................... 17. ...................................... 18. , ........ 19. ....................................................................................... 20. ..................................................... : , .......................................................... ................................................................................................................. ................................................................................................ .................................................................................................................. ............................................................................................. 02299 11.07.2000 . ( .) www.anakharsis.ru. e mail: pr.publishers@mtu net.ru.

119002, . , . ., 4, . 2, 14, .

.: 2416127, : 2417608.

25.09.2002 . 60 90/16. QuantAntiqua .

. . . . . 10. 2000 .

Pages:     | 1 |   ...   | 2 | 3 ||



2011 www.dissers.ru -

, .
, , , , 1-2 .